[{"article": "\"Migraine is one of the most disabling conditions known to man, but patients need to know that there is hope,\" says Stephen Silberstein, a neurologist at Thomas Jefferson University in Philadelphia and lead author of the guidelines from the American Academy of Neurology and the American Headache Society.\nNot everyone with migraines needs prevention medicine.\nThat's what happened to Emily Guzan, 26, a lawyer from Pittsburgh who was diagnosed with migraine in 2008.\nStill others try the treatments and decide they don't work or have unacceptable side effects.\nThey were presented at an academy meeting and published in the journal Neurology.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story was not based solely or largely on a press release.", "answer": 1}, {"article": "Chinese herbal medicine increased IELT by about two minutes, Ayurvedic herbal medicine increased IELT by nearly a minute and topical cream increased IELT by more than eight minutes.\nWhen they were reported, the adverse effects were generally mild, the study team writes.\n\u201cIt\u2019s important to evaluate the evidence for other therapies,\u201d she told Reuters Health by email.\nIn some instances, a combination of traditional and alternative options was the most effective.\nIn addition, the authors write, the studies are so different, it\u2019s tough to draw conclusions about the different options.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The range of quoted experts and the comprehensiveness of this story would suggest there isn\u2019t an over-reliance on a news release.", "answer": 1}, {"article": "Jan. 24, 2011 -- Using electrical pulses to stimulate nerve centers deep within the brain may reduce high blood pressure that can\u2019t be controlled with medication, a case report shows.\nThe case study is published in the Jan. 25 issue of Neurology.\nThat was a surprise because experts had long thought that pain had to be reduced to see a reduction in blood pressure.\n\u201cPain creates stress and that can have an effect on one\u2019s blood pressure,\u201d says Nikunj J. Patel, MD, a neurosurgeon at Frenchay Hospital in Bristol, U.K., and an author of the case study.\nThough his pain eventually returned after four months, his doctors report that their patient\u2019s previously uncontrolled blood pressure has remained normal for nearly three years.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "This story includes two interviews and includes much more detail than this\u00a0news release.", "answer": 1}, {"article": "Lung cancer is the No.\nBut Dr. David Gutterman, president of the American College of Chest Physicians, said more research would be needed before this could be proposed.\nMetformin, an older and cheaper drug available generically, had a more powerful effect than newer drugs called thiazolidinediones, TZDs or glitazones, the researchers said.\n\u201cOur study, as well as other research, suggests an association between metformin and/or TZD use and the risk of developing lung cancer,\u201d said Dr. Peter Mazzone of the Cleveland Clinic in Ohio, who led the study.\n\u201cHowever, unique to this study, we have been able to report less advanced cancer in those who do develop cancer, a decreased frequency of squamous cell and small cell carcinomas, and improved survival, when controlled for stage, in people taking metformin and/or TZDs.\u201d\n\nThe team reviewed the medical records of 157 lung cancer survivors with diabetes.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "This was a judgment call. A good deal of the article seems to be derived from the ACCP statement on the study. All of its quotes, including the one from the independent source, appear in that statement. The article does attribute a metformin statistic taken verbatim from this source.\nYes, there is some reporting about context.\nBut we think it is wrong to lift quotes from a news release without attributing the actual source.\u00a0 They were not collected in independent reporting.  ", "answer": 0}, {"article": "Dextromethorphan is a cough suppressant commonly found in over-the-counter cough medicines, and quinidine is a drug used to control heart rhythm disorders.\n\u201cFifty-five percent of the people who were on drugs had a 50 percent reduction in their agitation,\u201d said the lead author, Dr. Jeffrey L. Cummings, director of the Cleveland Clinic Lou Ruvo Center for Brain Health.\nThere are no currently approved treatments for agitation, and we\u2019re very enthusiastic about this finding.\u201d\n\nCorrection: October 8, 2015 \n\nA report in the In Brief column on Sept. 29 about a combination drug that could ease the agitation of Alzheimer\u2019s disease described incorrectly a disorder treated with the combination drug, dextromethorphan and quinidine.\nResearchers then rated them using a well-validated scale that measures aggression and agitation.\nNow researchers report that a combination drug already in use for treating certain neurological problems may be a better remedy.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "Although Avanir pharmaceuticals issued a news release for the study, the Times apparently conducted an interview with the lead author, demonstrating original reporting that went beyond the news release.", "answer": 1}, {"article": "AMHERST, Mass.\nBoutot and Bertone-Johnson add, \"Though relatively few women in our study consumed very high levels of vegetable protein and our power for analyses of more extreme intake levels was limited, women consuming 9 or more percent of their calories from vegetable protein had a hazard ratio of 0.41 (95 percent confidence interval = 0.19-0.88)\" compared to those eating less than 4 percent.\nFew studies have evaluated how protein intake is associated with menopause timing, they add, and to their knowledge this is the first to look specifically at early menopause.\nEarly menopause, the cessation of ovarian function before age 45, affects about 10 percent of women and is associated with higher risk of cardiovascular disease, osteoporosis and early cognitive decline, the authors note.\n\"A better understanding of how dietary vegetable protein intake is associated with ovarian aging may identify ways for women to modify their risk of early onset menopause and associated health conditions,\" write first author and then-graduate student Maegan Boutot, with her advisor, professor Elizabeth Bertone-Johnson.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "We commend the use of the word \u201cmodest\u201d in the sub-headline to describe the effect of vegetable protein on early menopause risk. But the news release makes missteps including the use of the word \u201csignificant,\u201d which might confuse some readers into believing the study shows a significant impact on early menopause risk when in fact it appears to mean the data is statistically significant, or reliable.\nFrequently, news reports about studies showing an association between food and health outcomes imply a causal relationship, which can\u2019t be shown with a single study based on observations. This one does just that when it states in the headline and the lead that eating more vegetable protein \u201cmay protect against early menopause.\u201d We wish news releases based on observational studies would be more upfront about limitations when describing the research. Adding a descriptor such as \u201cthese are useful findings that need further study\u201d would help.\nThe following quote also may leave readers with the idea that they can control their reproductive future based on this study\u2019s results: \u201cA better understanding of how dietary vegetable protein intake is associated with ovarian aging may identify ways for women to modify their risk of early onset menopause and associated health conditions.\u201d Giving women better information so they can control of their health is a laudable goal, but this study doesn\u2019t achieve that, and the news release should have made that more clear.\nFurther, the lead confuses matters by citing \u201cfoods such as whole grains, soy and tofu\u201d when the foods that accounted for the greatest variation in vegetable protein intake in the study were pasta, dark bread, and cereal.", "answer": 0}, {"article": "A large, new study may be reassuring to women considering mastectomies because of a history of breast cancer in their families.\n\nStanford University researchers affirmed that women with mothers and sisters who carry one of the BRCA gene mutations but who aren't carriers themselves don't have an especially heightened risk of breast cancer.", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The study includes interviews with experts who were not involved with the current research, so we can be sure the story wasn\u2019t based on a press release.", "answer": 1}, {"article": "Scientists hypothesize that the electrical currents may disrupt bacteria in two ways: by interrupting the production of chemical messages that instruct bacteria to develop biofilms and by weakening the molecular structure of existing biofilms, potentially making them more susceptible to antibiotics or the body\u2019s natural immune response.\n\u201cThis technology has a long shelf life and is compact enough to be put into any field medical kit.\nThe content of this release is solely the responsibility of the CCTS and does not necessarily represent the official views of the NIH.\nIt could be applied immediately to wounds help keep bacteria from mobilizing and start promoting healing until the soldier could be transported to a facility for more intensive medical care.\u201d\n\nThe team already has interest from several industry partners, and is hoping to begin testing the new technology in patients before the end of the year to determine optimal treatment duration and more about the healing effects of electrical fields on skin cells on a molecular level.\nRoy also notes that the U. S. Department of Defense is very interested in the dressing as a temporary measure to help prevent infection in soldiers wounded on the battle front.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "The opening paragraph of the news release calls the\u00a0research a\u00a0\u201cpotentially transformative solution\u201d to a serious health problem. It says the \u201cdesign significantly advances existing FDA-approved wireless electroceutical dressing\u201d and that\u00a0 \u201cthe U. S. Department of Defense is very interested in the dressing.\u201d These statements are basically editorial comment not backed up by any data or supporting information.", "answer": 0}, {"article": "The study, conducted at the University of Texas M.D.\nAnderson's department of health disparities and the study's principal investigator here.\nA serving was a half-cup.\nBut he also acknowledged the results so far were a surprise.\nAbout 10 percent in both groups died, the vast majority from breast cancer.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "Does not appear to rely exclusively on a press release.", "answer": 1}, {"article": "To place an electronic embedded link to this study in your story: This link will be live at the embargo time: http://jamanetwork.com/journals/jamasurgery/fullarticle/10.1001/jamasurg.2016.4219\n\nIn a study published online by JAMA Surgery, Daniel E. Hall, M.D., M.Div., M.H.Sc., of the Veterans Affairs Pittsburgh Healthcare System and University of Pittsburgh, and colleagues examined the effect of a Frailty Screening Initiative (FSI) on death and complications by comparing the surgical outcomes of patients treated before and after implementation of the FSI.\nEMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, NOVEMBER 30, 2016\n\nAlso available at the For the Media website, the commentary \u201cA Call for Frailty Screening in the Preoperative Setting,\u201d by Anne M. Suskind, M.D., M.S., and Emily Finlayson, M.D., M.S., of the University of California, San Francisco.\n\u201cThe ultimate cause of the survival benefit is likely multifactorial, including changes in preoperative decision making, intraoperative management, and postoperative rescue,\u201d the authors write.\n\u201cThis study reveals the feasibility of facility-wide frailty screening in elective surgical populations.\nPlease see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, etc.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "There is no unjustifiable language in the news release.", "answer": 1}, {"article": "Once a person reaches puberty, the next five years are vitally important in this respect.\"\nDespite the many health benefits of cycling and swimming, the study found little difference in bone development between cyclists, swimmers and the control group.\nThough swimming and cycling have proven health benefits, the scientists said their study \"raises a question\" about whether they are good for bone development due to the non-weight bearing training - and they say young swimmers and cyclists could benefit from more weight-bearing exercise in training regimes.\nThe results showed footballers had higher BMC than swimmers and cyclists after one year of sport-specific training.\nIn a study comparing adolescent footballers to swimmers, cyclists and a control group of boys not involved in regular sport, scientists at the University of Exeter found football led to significantly better bones after one year of training.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "The headline and first sentence of the news release state that playing football improves bone development in boys, but the data suggest that for all but one measure (a test of vitamin D levels), there were no significant differences between boys who played football and active, non-sports-involved boys. Thus, although playing football likely does improve bone development, this study did not show that it improved bone development over active participation in other weight-bearing sports such as running, tennis, weight-lifting, etc. In addition, because the study only examined boys competing at high levels in their sports, it provides little information about the value of more casual participation in soccer.", "answer": 0}, {"article": "Migraine symptoms, which can be debilitating for many people, are the sixth leading cause of disability, according to the World Health Organization.\nThis data is clinically significant.\nIt's safe, easy to use and noninvasive.\nThe U.S. Food and Drug Administration already had approved the sTMS device for the acute treatment of migraine with aura.\nBased on the current study and prior studies in acute migraine attack treatment, sTMS not only helps to stop a migraine attack, but it also helps prevent them.\"\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "The release doesn\u2019t rely on unjustifiable language.", "answer": 1}, {"article": "Many back patients are afraid certain movements will cause them pain, so they avoid them.\nThe program led to a significant and clinically important reduction of pain, she said.\nThe report was published online April 16 in JAMA Neurology.\nThe regimen included the best known exercises for back pain and general exercises, she said.\nWhereas back pain studies involving exercise and drugs have shown changes to the brain's gray matter, the program in this study found no brain changes, Malfliet said.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story did not appear to rely on a news release.", "answer": 1}, {"article": "Newswise \u2014 Baltimore, Md.\n\u201cBy continuing to develop a comprehensive thermal oncology program, we are giving patients more effective treatment options and therefore another reason to hope for better outcomes.\u201d\n\n\u201cThe Maryland Proton Treatment Center has achieved another milestone by becoming the first center to offer both deep-thermal therapy and proton therapy,\u201d says E. Albert Reece, MD, PhD, MBA, Executive Vice President for Medical Affairs at UM Baltimore and the John Z. and Akiko K. Bowers Distinguished Professor and dean at UMSOM.\nThe acquisition of the deep-tissue thermal therapy system was made possible by donations from Jack and Emily Howell and the Middendorf Foundation, Inc.\n\n\u201cWithin the Department of Radiation Oncology and throughout our cancer center, we strive to make every available tool in the cancer-fighting toolbox available to our patients,\u201d says William F. Regine, MD, FACR, FACRO, the Isadore & Fannie Schneider Foxman Endowed Chair and Professor of radiation oncology at UMSOM and chair of radiation oncology at UMGCCC.\n\u201cEarly research suggests that adding thermal therapy to proton-beam therapy may be associated with an even greater benefit than when combined with standard radiation therapy, and we are excited to be at the forefront of making this combination therapy available to cancer patients,\u201d says Dr. Vujaskovic, an internationally recognized expert in hyperthermic oncology.\nOne of the goals of MPTC is to remain cost-neutral to insurance providers, meaning patients pay the same for proton treatment as they would for other more conventionally available intensity-modulated treatments at the University of Maryland Medical Center.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "The release employs unjustified language throughout. Some examples:\n\u2022 It calls proton therapy \u201cmore effective\u201d but that\u2019s not supported by data in the release. \u2022 It refers to proton therapy \u201cas a potential way to boost survival chances for certain cancer patients\u201d \u2014 Which is it? More effective (denoting evidence in hand) or \u201ca potential way\u2026\u201d (denoting future potential)? \u2022 When you read claims like \u201cthe only facility that\u2026\u201d let the buyer beware. \u2022 It states \u201cresearch has shown\u2026studies have found\u201d \u2014 What research? Which studies? None are named or linked. \u2022 \u201cThe Maryland Proton Treatment Center has achieved another milestone by becoming the first center to offer both deep-thermal therapy and proton therapy\u2026 It\u2019s this type of innovation that sets MPTC apart from other proton treatment centers.\u201d How should milestone and innovation be defined? By offering something? Or by presenting evidence? We\u2019d say the latter.", "answer": 0}, {"article": "First published on June 22, 2006 at 12:00 am\nOther researchers involved in the study were affiliated with Duke University, Stanford University, the University of Arkansas, Johns Hopkins University, the Veterans Affairs health care system, and Pfizer, which supported the project.\nDr. Julia Zehr, a Michigan State University researcher who led the study, said the findings suggest that biological factors may influence those behaviors, not just the psychological effect of changes in body composition during puberty.\nBut Dr. George Merriam, a professor of medicine at the University of Washington, cautioned that much more study is needed to determine whether the medication should become widely available to help counteract the effects of aging.\nDr. Merriam said Merck and other companies also are investigating similar treatments.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "We can\u2019t be sure if the story relied largely on information from a news release, although much of the material in the story appears in a University of Pittsburgh news release at the time of The International Congress of Neuroendocrinology, where the research was presented. ", "answer": 2}, {"article": "For more information, visit www.idri.org.\nReed, along with scientists from a variety of scientific organizations recently published \"Innovative tools and approaches to end the transmission of Mycobacterium leprae\" in , outlining what is needed to achieve this goal.\nAnd, it may be that this vaccine can lead to interruption of the transmission of leprosy all together.\n\"While previous attempts have used vaccines primarily developed for other diseases, this is the first totally defined vaccine candidate developed specifically for leprosy, using the latest technologies and offering no less than those exposed to leprosy deserve,\" said Steven Reed, Ph.D., IDRI President, CEO & Founder.\nA viable vaccine to prevent and/or treat leprosy is the next step in the effort to bring this disease to an end.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "The release is unsatisfactory here on multiple fronts. First, a researcher is quoted calling the\u00a0\u00a0 phase 1 study a \u201cbreakthrough\u201d which it clearly isn\u2019t.\nSecond, the release states that, because of LepVax, \u201cit could be possible to prevent disease development in people already infected with the leprosy bacterium.\u201d It could just as easily have said, \u201cit may not be possible to prevent disease development.\u201d\nThirdly, if one is going to make bold claims, where is the evidence to back it up? The only reference we could find to the role of LepVax in limiting the development of leprosy was in a 2014 report from a Novartis Foundation meeting, which referred to a study that was done in an animal model involving 21 armadillos. Both of those concerns, in conjunction with our concerns about calling the beginning of a phase 1 trial a \u201csignificant step forward\u201d in leprosy prevention/treatment, give this release a Not Satisfactory rating.", "answer": 0}, {"article": "\u2022 Prostatectomy, the surgical removal of the prostate gland, which can be done with minimally invasive techniques and robotic assistance;\n\u2022 Brachytherapy, in which doctors implant numerous small radioactive seeds about the size of a grain of rice into the prostate gland using multiple large needles inserted through the skin in the operating room.\nTerry Martin of McKinney, Texas, - about an hour outside Dallas - said the fewer number of treatments was a compelling advantage when he was evaluating treatment options.\n\"The current form of radiation is 44 treatments given over nine weeks.\n\"SBRT is both more convenient and has increased potency.\"\nDecrease in erectile function was seen in 25 percent of patients, fewer than with conventional radiation or surgery, said Dr. Hannan.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "We question the use of \u201ccure\u201d in the headline. And, while the current report\u00a0did focus on \u201cfreedom from biochemical failure (i.e., no increase in PSA)\u201d \u2014 which is not the same as cure \u2014 the primary intention of the study was to assess toxicity. \u00a0Talking about a \u201cstrikingly\u201d high cure rate is misleading given the absence of a control group.", "answer": 0}, {"article": "Dr. Jeffrey Tice, an internist at the University of California, San Francisco, who wrote an editorial accompanying the study, said: \"With hormones, we really were thinking we were preventing a lot of diseases and it was good for the long term.\nThe poor rating often meant a study, even though well conducted, was too small or too short to be conclusive.\nShe took a cautious view because she and her colleagues found that there was relatively little reliable data on using the drugs for hot flashes.\nOf 10 studies on antidepressants, for instance, the researchers judged only two of the studies to be good, and the rest fair or poor.\nThere were only two studies for Effexor, just one of which suggested it might help.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "Not enough information to determine if this relies on a JAMA press release. Language is very similar to the introduction of the journal article and only study authors and the physican who wrote a JAMA editorial on the study are cited. ", "answer": 2}, {"article": "\u201cBut it is definitely a breakthrough.\n\u201cReactions from the oral challenges at the end of the study were much milder than prior to treatment,\u201d Tilles said, according to EurekAlert.\n\u201cThis is not a quick fix, and it doesn\u2019t mean people with peanut allergy will be able to eat peanuts whenever they want,\u201d Jay Lieberman, MD, vice chair of the ACAAI Food Allergy Committee and study co-author, said, according to EurekAlert.\nThe study\u2019s authors noted that patients would need to stay on the drug in order to receive protection against the allergy.\nParticipants ingested the peanut protein under the supervision of a board-certified allergist as part of a process called an oral food challenge (OFC).\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story appears to be based on a news release from the American College of Allergy, Asthma, and Immunology. The quotes in the story were attributed to EurekAlert, which published the organization\u2019s news release.", "answer": 0}, {"article": "The ATS publishes three journals, the American Journal of Respiratory and Critical Care Medicine, the American Journal of Respiratory Cell and Molecular Biology and the Annals of the American Thoracic Society.\nSumming up the findings of the current study, Dr. McEvoy said that a relatively low dosage of vitamin C may present \u201ca safe and inexpensive intervention that has the potential to help lung health of millions of infants worldwide.\u201d\n\nHowever, she added, helping mothers quit smoking should remain the primary goal for health professionals and public health officials.\nThe researchers wrote that study results support the hypothesis that oxidative stress caused by cigarette smoking reduces the amount of ascorbic acid, a component of vitamin C, available to the body.\nInfants in this study will continue to be followed to track their lung function and respiratory outcomes.\n\u201cSmoking during pregnancy reflects the highly addictive nature of nicotine that disproportionately affects the most vulnerable populations,\u201d said Dr. McEvoy, lead study author and professor of pediatrics at Oregon Health & Science University.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "Even with the use of \u201cmay,\u201d the headline is unjustified because it presumes the surrogate marker (lung function test) used in this study accurately reflects future lung health.\nIn other words, improvements of unknown future significance in some lung tests in the infants whose mothers took vitamin C does not justify implications that vitamin C is going to be protective.", "answer": 0}, {"article": "No prior studies showed zinc lozenge use -- even up to 150 mg per day -- might cause harm aside from bad taste or constipation, Hemila said, and the most recent trial on zinc acetate indicated no significant differences between zinc and placebo groups in adverse effects even though the daily zinc dose was 92 mg.\n\nDr. Lisa Winston, an epidemiologist at San Francisco General Hospital, praised the study as a \"pretty good synthesis of the data,\" although she noted that the trials Hemila reviewed involved small numbers of participants.\nThe study is published in The Open Respiratory Medicine Journal.\nAllowing the lozenge to dissolve instead of swallowing it seemed to provide a therapeutic effect.\n\"It's an area of controversy and question .\n\"Much of the variation in the published study findings can be explained by the daily dose of zinc administered in the zinc lozenges,\" said Hemila, who funded the research himself.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story does not rely solely on a news release.", "answer": 1}, {"article": "Rates are rising, in part because tanning became fashionable.\nNew data about to be released to a meeting of cancer specialists shows that 40 percent of the patients who have been taking the drug are still alive three years later.\nIt was bad enough for 8 percent of patients that they stopped taking it.\nThe drugs must be infused and they are pricey.\nThe cancer drug that former president Jimmy Carter says made his melanoma seemingly disappear has helped about 40 percent of similar patients survive for as long as three years, oncologists said Wednesday.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "Though NBC News\u2019 story\u00a0quotes\u00a0a press release from the American Society of Clinical Oncology, it\u2019s not gratuitous and the vast majority of the article\u00a0is comprised mostly of original reporting.", "answer": 1}, {"article": "Chronic insomnia is defined by the Diagnostic and Statistical Manual of Mental Disorders as sleeping poorly at least three nights a week for a month or longer, despite adequate opportunity for a full night's sleep.\nAdditional training in the therapy for behavioral health providers in all branches of the military is needed, he said.\nThe study was published in SLEEP, the official journal of the Sleep Research Society.\nHe noted that that cognitive behavioral therapy is \"a multifaceted intervention that can be difficult to administer without the benefit of a therapist.\"\nAll completed one week of sleep monitoring by keeping sleep diaries and wearing activity monitors.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "There was no inappropriate or unjustifiable language used to describe this study.", "answer": 1}, {"article": "Espiritu started work at Henry Ford just as the program was starting, and she remembers the initial staff meetings: \"There was a lot of, 'How can you do this?\nThe list includes her therapists' phone numbers.\nOfficials at Henry Ford say they haven't analyzed the costs.\nThat approach saved the life of a woman who prefers to be known only by her first name, Lynn.\nShe agreed to share her medical history on the condition that we not use her full name to protect her privacy.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story does not appear to be based on a news release. (The most recent news release we could find on the Henry Ford Health System program dates back to 2010.)", "answer": 1}, {"article": "Then President Richard Nixon declared drugs \u201cpublic enemy No.\nThat said, when studied under controlled and supervised conditions, these chemicals have not been found to cause lasting negative health consequences, the Canadian Medical Association Journal review noted.\nTwelve out of 15 patients in this small study had given up smoking six months after a psilocybin-assisted therapy session.\nAll of which adds up to a compelling argument that psychedelics \u201cshould be the focus of intensive study for treating mental illness,\u201d Wood says.\nBut that\u2019s changing.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "This shows no hallmarks of having been generated by, or dependent upon, a news release.", "answer": 1}, {"article": "In more than 22% of cases, implantable defibrillators are given to heart patients who don\u2019t meet the guidelines for receiving the pricey devices, according to a study just published in JAMA.\n\nThe research, based on 111,707 cases submitted to a national registry over a three-and-a-half-year period, also finds that those patients who didn\u2019t meet the guidelines had a higher risk of dying in the hospital and of complications from the implantation.\n\nICDs, which can cost north of $30,000, monitor the rhythm of the \u2026", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story does not rely on a news release.", "answer": 1}, {"article": "Oct. 17, 2010 -- Women aged 65 and older are advised to undergo bone mineral density (BMD) screening every two years, but those with normal results at age 67 may be able to wait 10 years before their next screening test, a new study suggests.\nThe new findings are slated to be presented at the annual meeting of the American Society for Bone Mineral Research in Toronto.\nThat was longer than we expected, and it's great news for this group of women.\"\n\"Our study found it would take about 16 years for 10 percent of women in the highest bone density ranges to develop osteoporosis.\nTheir findings are based on the women's T-score, which is a measure of bone density.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "One quote \u2013 the story admits \u2013 comes from a news release.\u00a0 But there is evidence of independent reporting elsewhere.", "answer": 1}, {"article": "Reiki, a therapy in which hands are placed lightly on the body or just above it, is increasingly being used to reduce cancer-related fatigue, anxiety, nausea and pain. Several studies suggest a benefit to patients, but scientists say more large, rigorous studies are needed.\n\nCancer patients\u2014due to the disease and to side effects of chemotherapy\u2014often suffer from severe mental and physical fatigue, doctors say. Anxiety, nausea and pain are also common. In recent years, many cancer centers have been offering Reiki, a form of...", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story did not rely on a news release.", "answer": 1}, {"article": "Supplements may be an additional source of DHA, but an editorial in the same issue, by Dr. Martha Clare Morris, an associate professor of medicine at Rush University Medical Center in Chicago, points out that there are no published human studies of the effects of omega-3 fatty acid supplementation.\nOther dietary intake and genetic propensities probably account for the rest.\nEating fish is not a guarantee of having high levels of DHA.\nDr. Ernst J. Schaefer, the lead author of the study, was cautious in interpreting the results.\nThe study was financed in part by Martek, a concern that manufactures DHA, and one author received a grant from Pfizer, France.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "Does not appear to rely on a press release.", "answer": 1}, {"article": "A variety of detox diets claim to flush toxins out of the body, aid weight loss and even clear up skin.\nAnd while the Reeds admitted it was a lot of pills and they had to stay close to the bathroom at first, they believe the cleanse worked.\nRenowned weight loss surgeon, Dr. Mitchell Roslin said the short-term payoff is all in the science.\nVolpe said she noticed results when her pants began getting baggy around her legs.\nBecause of that promised quick fix, the detox diet business is booming.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "We can\u2019t be sure if the story relied largely on a news release.\u00a0 We don\u2019t know why they did the story now. We do judge that the story had a clear favorable bias for a company\u2019s products. ", "answer": 2}, {"article": "In a twist in the debate about the safety of menopause hormones, new research suggests the real problem may not be the hormone itself, but the fact that it's typically swallowed as a pill.\n\nThis week, the medical journal Circulation offers some of the strongest evidence yet that the risks of hormones are dramatically reduced when the drugs are absorbed through the skin in patches and gels rather than taken as pills. The study by French researchers showed that one of the most serious risks associated with hormone use -- blood...", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "Because the story quotes multiple, independent experts, the reader can assume the story does not rely on a press release as the sole source of information.", "answer": 1}, {"article": "Gene therapy proposed for bleeding disorders involves introducing DNA carrying the code to produce the specific clotting factor lacking in patients.\nThe CHOP team collaborated with scientists at UNC who have a long-established colony of dogs for hematology research.\nBased on kidney function, liver function, and blood measurements in the dogs, the treatment was safe, and did not elicit unwanted immune responses.\nThis success in large animals holds considerable potential for a safe, effective and long-lasting new treatment in humans with the same bleeding disorder.\nThe current study sets the stage for clinical trials in humans.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "We were pleased to see proof-of-concept in the headline, because this is a very useful way to immediately alert readers that an idea has been validated, but not a therapy for human patients.", "answer": 1}, {"article": "Lupus is an autoimmune disease, in which the defense system against pathogens attacks the body\u2019s own tissues.\nOn Friday, it closed at $3.32 a share.\nMore patients on the drug had the required improvement in symptom severity.\nResults from a second Phase 3 trial are due in November.\nIt also changed the measurement of success and lengthened the trial to give the drug more time to work.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "Does not appear to rely exclusively on a press release.", "answer": 1}, {"article": "About 35% of U.S. adults take calcium supplements, alone or in multivitamins, according to a recent report in the medical journal JAMA.\nHe was not involved in the research.\nThe larger review did not include all potentially relevant studies, says Erin Michos, an associate professor of medicine and epidemiology who led the Johns Hopkins study.\nNot everyone is convinced.\n\u201cIf you look at the overall totality of the evidence, there\u2019s a lack of association between supplement use and heart attack and other cardiovascular events,\u201d says Manson, who co-wrote an editorial accompanying the review.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story does not appear to rely on a news release.", "answer": 1}, {"article": "\"You start doing research on that type of tumor, and you're saying, 'Oh my God, you're history.'\nThe chemo failure was the latest in a string of personal setbacks.\nThey all found the same thing.\nThere are side effects, of course.\nOnly for her it wasn't.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The article went beyond any press release.", "answer": 1}, {"article": "A study published in this month's issue of the Archives of Neurology found that the diet might protect against blood-vessel damage in the brain, reducing the risks of stroke and memory loss.\nNow, it may be good for the brain as well.\nNow, it may be good for the brain as well.\nWe've long known that the Mediterranean diet is good for the heart.\nWe've long known that the Mediterranean diet is good for the heart.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "We can\u2019t be sure of the extent to which the story may have been influenced by a news release. We do know that it included no direct quotes, no independent perspectives.", "answer": 2}, {"article": "; Chloe E. Bird, Ph.D.; Kim Kimminau, Ph.D.; Karen Wambach, Ph.D.; and Marcia L. Stefanick, Ph.D.\nThis is among the first studies to examine breastfeeding and a possible relationship to stroke risk for mothers, as well as how such a relationship might vary by ethnicity.\nHowever, because the Women's Health Initiative is large, researchers were able to adjust for many characteristics, and the effects of breastfeeding remained strong, Jacobson said.\n\u2022 Available multimedia including photos and an audio interview are on the right column of the release link - https:/\n\u2022 Story on previous JAHA study (June 21, 2018): Breastfeeding may reduce a mother's heart attack and stroke risk\n\u2022 For updates and new science from JAHA, follow @JAHA_AHA\n\nStatements and conclusions of study authors published in American Heart Association scientific journals are solely those of the study authors and do not necessarily reflect the association's policy or position.\nThe Association has strict policies to prevent these relationships from influencing the science content.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "The release uses responsible, cautious language. The recommendation to breastfeed to prevent stroke based on observational research may be an overreach, however.", "answer": 1}, {"article": "Foxman B, Barlow R, D'Arcy H, Gillespie B and Sobel JD.\nThe review explains that the medicinal properties of cranberries may be attributed to their unique polyphenol, proanthocyanidins - or PACs, for short.\nThe Cranberry Institute is funded voluntarily by Supporting Members that handle, process, and sell cranberries.\n\"As one of the oldest alternative therapies and U.S.-born berries, independent research such as this not only provides public health benefits, it revitalizes the enthusiasm for cranberry products year-round.\nIt is estimated that one third of women in the United States will get a UTI by the age of 24.2\n\n\"Findings like this,\" adds Dr. Luis, \"give practitioners a viable, inexpensive, non-antibiotic option to help patients reduce the recurrence of an uncomfortable and potentially debilitating infection.\"\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "As with the conflict-of-interest section, this earns a satisfactory rating, but includes some odd language that is worth noting. First of all, there is no unjustifiable language in regard to the study itself \u2014 thus the satisfactory rating. However, the release also quotes the director of an industry-funded organization, who notes that this research \u201crevitalizes the enthusiasm for cranberry products year-round.\u201d The relevant paragraph comes as a distinct non sequitur and gives the release the tone of an advertisement, rather than an attempt to raise awareness of recent health research findings.", "answer": 1}, {"article": "There was, however, a 70 percent reduction in chlamydia infections and cases of syphilis decreased by 73 percent.\nThe results can\u2019t be taken in isolation, others experts warned.\nThe Bill and Melinda Gates Foundation was one of its funders.\nLike Molina and his co-authors, they said STI preventive use at this point is premature.\n\u201cMy message with that study would be that we need to do more research to prevent STIs \u2014 because that\u2019s a concern.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story includes quotes with researchers and independent sources that appear to be from original reporting.", "answer": 1}, {"article": "\"Wow!\"\nNow, to be perfectly clear, all we know about the latest data is from press releases.\nAnd the drug hasn't been submitted for review by the Food and Drug Administration, though Vertex expects to do that later this year.\nBut these results, even with plenty of caveats, suggest the drug is on the right track.\nBut a key takeaway is that the medicine gets at a root cause of cystic fibrosis in some people rather than just relieving their symptoms.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "It admits it relied on a news release.\u00a0 But as we noted in our review of a competing NY Times story, while the study information is from a news release, the story did use several other sources. And, while we would normally chastise this type of reporting, we think that in this instance it is reasonable. Cystic fibrosis is a terrible disease that has defied attempts at a cure or even a satisfactory treatment. A drug that shows promise, albeit with the information dissemination coming from a press release, is newsworthy.", "answer": 1}, {"article": "An estimated 25 million to 45 million Americans suffer from irritable bowel syndrome, or IBS, a gastrointestinal condition that can cause miserable symptoms.\nMaking it worse for many patients, there hasn't been a conclusive test to diagnose what's wrong with them.\nShe got the new blood test to confirm her diagnosis, and when it came back positive, she said she felt a sense of relief knowing IBS wasn't all in her head.\nBut that could finally change with the introduction of two simple new blood tests for spotting the disease.\nIrina Obenauer was diagnosed with IBS years ago after suffering from diarrhea and bloating, but it took doctors a long time to rule out other possible diagnoses first.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The description of \u201ctwo simple blood tests\u201d is suspiciously similar to copy from a news release issued a few days before the story was posted. And certainly the narrative of the story mirrors what we found in our review of that news release. But since the story does include at least one comment that puts a brake on some of the claims made by the manufacturer, we\u2019ll give the benefit of the doubt here and award a Satisfactory.", "answer": 1}, {"article": "A study believed to be the largest of its kind suggests that the physical aspects of yoga are effective at relieving low back pain, but it didn't find any evidence that yoga provided broader mental benefits.\n\nThe study, funded by the National Institutes of Health's National Center for Complementary and Alternative Medicine, was published online Monday in the Archives of Internal Medicine. It was lead by researchers at Seattle's Group Health Research Institute.", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The article was not based on a press release.\n\n\n\n\n\n\n", "answer": 1}, {"article": "Up to 30% of men suffer some degree of premature ejaculation, defined as ejaculation that occurs within one minute of vaginal penetration.\nThe numbers aren't huge.\nThe rest of the men used a placebo spray.\nIt's the No.\nNonetheless, doctors like Irwin Goldstein, MD, director of San Diego Sexual Medicine at Alvarado Hospital in San Diego, tell WebMD they're excited because this is the first time a drug is being rigorously tested for men with really serious premature ejaculation problems.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "It\u2019s clear that the story did not rely solely on a news release. ", "answer": 1}, {"article": "Compared to women who received inactive placebo pills, those who took flibanserin at bedtime were more likely to get relief from self-reported sexual distress, to experience more sexual desire, and to have more sexually satisfying experiences.\nUpdated reports on data from the North American \"Daisy\" and \"Violet\" studies were made by Krychman and other researchers at this week's annual meeting of the American College of Obstetricians and Gynecologists in San Francisco.\nIn the 24-week \"Bouquet\" studies (each of the Boehringer Ingelheim-funded studies is named after a flower), there were few drug-related side effects.\nHowever, it's not an on-demand treatment.\nThe findings come from phase III clinical trials that drugmaker Boehringer Ingelheim hopes will convince the FDA to approve flibanserin for the treatment of hypoactive sexual desire disorder (HSDD).\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story was apparently based on\u00a0research presented in abstract form\u00a0at the annual clinical meeting of the American College of Gynecologists and Obstetricians, although this information\u00a0has not been\u00a0published in independently, peer-referred scientific journals.\u00a0 \nThere is no direct evidence that it relied largely on a news release.\u00a0 In fact, the use of interviews with independent experts makes it clear that independent reporting took place. ", "answer": 1}, {"article": "\"Although this technique holds promise for identifying infants at risk for autism, it still needs to be determined whether the atypical patterns of brain activation are specific to autism,\" said Geraldine Dawson, chief science officer for Autism Speaks.\nThere are important limitations to the study, Adesman said.\nFurther work is needed to refine the test, Hirsch added.\n\"These are things that aren't known.\"\nThis test costs no more than a standard MRI, which runs around $1,500, Hirsch noted.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story does not rely on a news release.", "answer": 1}, {"article": "In an outpatient procedure under local anesthesia, doctors funneled a catheter into the patient's heart and removed peppercorn-sized bits of tissue from the part of the patient's heart that was unaffected by the heart attack.\nFurther research will hopefully also help answer those questions, she says.\nHe says that why this is happening is still unclear.\n\"That was unprecedented\" he says.\nShe is hopeful further studies will confirm these early results.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story goes beyond the Cedars-Sinai press release.\n\u00a0", "answer": 1}, {"article": "We're sorry, but we seem to have lost this page.", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "There is a press release, but this story goes beyond the release.", "answer": 1}, {"article": "Some of the stem cells did become heart muscle, Hare said; they also triggered the heart to produce more of its own stem cells which became new heart muscle as well, he said.\nIt worked in patients such as Eaton, whose heart attack was 11 years ago, Hare said.\nThe trial was primarily about the safety of the procedure, and all eight patients came through without significant side effects, he said.\nBy implication, it almost certainly improves the patient's health, although that was not directly measured in the small, early study.\n\u201cAlmost certainly, I would be deceased or in much worse shape had I not had the opportunity to be in this program.\u201d\n\nHare stressed that the current trial is only a small, run-up phase of extensive testing that will take up to five years and involve dozens of hospitals and hundreds of patients before winning U.S. Food and Drug Administration approval for routine use.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "This piece does not rely on a press release.\n", "answer": 1}, {"article": "Patients with heart disease or who are using antidepressants known as selective serotonin reuptake inhibitors should also be careful when taking sumatriptans, said Waltman, who added that she thought the patches \"are wonderful.\"\nAnother expert described the problem this way.\nOne concern, though, is cost, Waltman cautioned.\nResearch involving 800 patients ultimately led to the approval of Zecuity.\nIt's not clear how much the patches will cost, but the class of medications known as triptans can be expensive, as much as $300 a month (although sumatriptan now has a generic version), Waltman said.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "There\u00a0is enough original reporting that we can be sure this wasn\u2019t based on a press release.", "answer": 1}, {"article": "Dec. 7, 2012 -- A drug related to thalidomide may be more potent and less toxic than thalidomide, which is often used to treat lupus skin conditions.\nThe researchers note that the study dose was \u201cgenerally well-tolerated.\u201d No new nerve symptoms were reported.\nThey all were followed for seven to 30 months.\nIn more recent years it has been brought back to the market to treat a number of serious conditions, but its use is monitored closely to ensure that it is not taken by women who are pregnant or who might become pregnant.\nHe says about 75% of patients with affected skin will go into remission with these standard treatments.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story lists this news release as one of its sources.\u00a0 However, there isn\u2019t any clear evidence that the story relied solely or largely on it.", "answer": 1}, {"article": "It\u2019s called \"dry needling,\" and it involves the insertion of thin, non-medicated solid needles into muscles or connective tissues.\nBut it said higher quality studies were needed.\nWhat are the risks?\nAbout 6,000 have taken courses in dry needling in the past few years, Zylstra says.\nBut testimonials are not scientific proof.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story does not rely on a news release.", "answer": 1}, {"article": "Normally, cells in the pancreas work to release insulin, a hormone that can process sugar and either send it to cells that need it for energy or store it as fat for future energy needs.\nThat points to an important lesson that Taylor hopes doctors and patients will learn from the results.\nAll of the people had been diagnosed with type 2 diabetes in the six years preceding the study.\nTaylor stresses that the study only addressed people diagnosed relatively recently \u2014 within the past six years \u2014 and that the effect may not apply to more long-term patients.\nTaylor says he intends to follow up on the people in the study for another four years to see if they are able to maintain their weight, and, if they are, whether they continue to remain in remission.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story does not appear to rely on the new release put out by The Lancet, the journal that published the study.", "answer": 1}, {"article": "of fat lost over 30 days.\nThe company develops IP-protected, science-backed branded ingredients from natural sources using cutting edge technologies.\n\"Capsimax is supported by multiple studies with findings showing safety, increased lipolysis and satiety and improved healthy body composition.\nThe company's centers of excellence are located in North America and India, whereas its cGMP and HACCP system-compliant manufacturing operations are located at multiple FDA inspected sites in India.\nCapsimax and OmniBead are trademarks of OmniActive Health Technologies Ltd.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "The release doesn\u2019t rely on sensational or unjustified language.", "answer": 1}, {"article": "A new, detailed mammography exam catches more cancers while causing fewer false alarms, according to the company that sells it. The downside, some physicians say, is that it costs more and delivers twice as much radiation as traditional mammograms.\n\nTomosynthesis, or three-dimensional mammography, has been available in the U.S. since February from Hologic Inc., Bedford, Mass. In just a few months, radiologists say they are finding cancers they would have missed with the standard exam.", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "It does not appear that the story relied solely on a news release, although there was certainly a lot of space given to the manufacturer\u2019s perspective.", "answer": 1}, {"article": "\"It's kind of an extreme makeover of a cell,\" said Douglas A. Melton, co-director of the Harvard Stem Cell Institute, who led the research.\nResearchers in the field, who have become accustomed to rapid advances, said they, too, were surprised by the advance.\nThe work was hailed as a welcome development even by critics of research involving embryonic stem cells, which can be coaxed to become any tissue in the body but are highly controversial because they are obtained by destroying embryos.\nMelton and other researchers cautioned that many years of research lay ahead to prove whether the development would translate into cures.\n\"It introduces a whole new paradigm for treating disease.\"\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "Does not appear to rely on a press release.", "answer": 1}, {"article": "The armpits, palms, and soles are often affected.\nThe study was small and the findings are preliminary.\nIt works, he says, by heating and destroying the sweat glands under the arm.\nHe presented the findings here at the annual meeting of the American Academy of Dermatology.\n\"Microfocused ultrasound appears to be effective and safe in the treatment of hyperhidrosis,\" Nestor says.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "It does not appear that the story relied on a news release.\nBut we must admit, we wonder about the rationale for picking this study out of the hundreds being reported on at the annual meeting for a story.", "answer": 1}, {"article": "Sigmund Freud often included one of his dogs in psychoanalysis sessions.\n\u201cThe literature does show it\u2019s not bad.\nIt might be an emotional-support animal prescribed by a mental health professional.\nCrossman\u2019s recent study at the Yale Innovative Interactions Lab was among the work being supported.\nThe pet-industry backed organization funds research on the topic.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story does not appear to be based on a news release.", "answer": 1}, {"article": "To compare the relative effectiveness of M-Y and Tamiflu in treating H1N1 influenza, the authors focused on 410 previously healthy patients who were diagnosed with a \"very mild\" form of the illness.\nAll of the herbs were screened for quality, and the M-Y mixture was deemed to meet Chinese safety standards.\nEven though the ephedra-containing herbal is not readily available in the United States, the M-Y herbal formula is available in many countries besides China, including Korea, Japan, India and Germany, the study authors noted.\nHowever, finding the medicine in the United States is difficult, if not impossible, given that it contains the stimulant ephedra.\nThe authors discuss their findings in the Aug. 16 issue of the Annals of Internal Medicine.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "This story was not based on a news release.", "answer": 1}, {"article": "But there were no significant differences in the reading rates of participants who had previous experience using the CCTV, compared to the reading rates of first-time CCTV users.\u201d\n\nAnother benefit is that many older adults feel stigmatized by using the traditional devices, because they identify them as having an impairment or disability.\nFor the study, the Concordia-based research team recruited 100 participants who ranged in age from 24 to 97.\nThe study's third co-author is Julie-Andr\u00e9e Marinier, from the Centre de recherche interdisciplinaire en r\u00e9adaptation du Montr\u00e9al m\u00e9tropolitain and \u00c9cole d'optom\u00e9trie at the Universit\u00e9 de Montr\u00e9al.\nIn Canada, that\u2019s roughly 3.6 million people.\nAnd that could help with stigmatization of the elderly and disabled.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "The release does not use unjustifiable language.", "answer": 1}, {"article": "Please see paper for the complete list.\n\u201cThe magnitude of improvement in these ten patients is unprecedented, providing additional objective evidence that this programmatic approach to cognitive decline is highly effective,\u201d Bredesen said.\nOther collaborators on the study include Edwin C. Amos, Jonathan Canick, Mary Ackerley, Cyrus Raji, Milan Fiala, and Jamila Ahdidan.\nTHE BREDESEN PROTOCOL, Dr. Bredesen\u2019s book describing for a lay audience the interventions described in this paper, will be released by Penguin Random House in May 2017.\n\u201cFollow up testing showed some of the patients going from abnormal to normal.\u201d\n\nOne of the more striking cases involved a 66-year old professional man whose neuropsychological testing was compatible with a diagnoses of MCI and whose PET scan showed reduced glucose utilization indicative of AD.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "There are several instances of unjustifiable language in the news release, given the fact that this was an uncontrolled 10-person study. Some examples:\n\u201cThe magnitude of improvement in these ten patients is unprecedented\u201d\n\u201cTransform the perception and reality of Alzheimer\u2019s disease from a death sentence to a preventable reversible condition\u201d\n\u201cNow we\u2019re recommending that people find out their genetic status as early as possible so they can go on prevention.\u201d", "answer": 0}, {"article": "Cardiac hybrid imaging combines coronary computed tomography angiography (CCTA) and myocardial perfusion imaging with single photon emission tomography (SPECT) to provide information on both stenosis and perfusion.\nThe present study now documents the prognostic importance of the comprehensive assessment provided by hybrid imaging.\"\nThe study supports CCTA use for an initial, noninvasive evaluation of patients with known or suspected stable coronary artery disease.\nDr. Kaufmann said that hybrid imaging findings could help guide treatment decisions, such as whether or not a patient should have a revascularization procedure such as bypass or angioplasty.\nThe shear stress information could help identify lesions that do not yet have an impact on ischemia but will in the future.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "The news release skirts the line when it makes the following recommendation:\nThe study supports CCTA use for an initial, noninvasive evaluation of patients with known or suspected stable coronary artery disease. No additional imaging would be necessary if the results were normal. If a lesion was evident, then clinicians could employ a nuclear scan to assess ischemia and take advantage of both modalities by fusing the results together to make a hybrid image.\nThere\u2019s no evidence provided in the news release or the study to back up the claim that this proposed two-step approach is more effective than the current practice.\nHowever, this statement is not quite egregious enough to merit a Not Satisfactory rating here, which we typically reserve for over-the-top claims of \u201cbreakthroughs\u201d and \u201cgame changers\u201d.", "answer": 1}, {"article": "\"They do research online, are more informed and sometimes go to the doctor demanding, 'I think I need an MRI.'\nA big lifestyle adjustment worked for Terri Bradford.\nBernstein says she sees lots of desperate patients like Bradford.\nHe only looked at otherwise healthy patients who suffered chronic headaches.\nBradford is not alone.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story does not rely on a news release.", "answer": 1}, {"article": "Previous research has also suggested that fructans stimulate the growth of beneficial bacteria in the large intestine in a way that increases the body's absorption of minerals, including calcium and magnesium, which are needed for bone growth.\nThe study was to be presented Tuesday at the national meeting of the American Chemical Society in San Francisco.\nTUESDAY, March 23, 2010 (HealthDay News) -- An ingredient in agave -- the plant used to make tequila -- may help fight bone-weakening osteoporosis and other diseases, Mexican researchers say.\nBut drinking tequila won't help, the study authors noted.\n\"These results suggest that the supplementation of the standard diet with agave fructans prevented bone loss and improved bone formation, indicating the important role of agave fructans on the maintenance of healthy bone,\" Lopez said.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story admits that it is based on \"background information in a news release from the American Chemical Society.\"", "answer": 0}, {"article": "Unlike the more common obstructive sleep apnea, in which the airway partially collapses and causes pauses in breathing, central sleep apnea (CSA) occurs when the brain fails to control breathing during sleep.\nThe study was funded by Respicardia.\nThe study is published today by The Lancet.\nAbraham is a consultant for the company.\n\"Currently, we don't have good treatments available.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "We did not find unjustifiable language.", "answer": 1}, {"article": "-- The use of medication to treat attention deficient hyperactivity disorder is linked to significantly lower risk for substance use problems in adolescents and adults with ADHD, according to a study led by researchers at Indiana University.\nOther authors on the study were Martin E. Rickert, a research scientist at IU; Kwan Hur, Robert D. Gibbons and Benjamin B. Lahey of the University of Chicago; and Zheng Chang, Arvid Sj\u00f6lander, Paul Lichtenstein and Henrik Larsson of the Karolinska Institute in Sweden.\nQuinn is a member of the lab of Brian M. D'Onofrio, a professor in the Department of Psychological and Brain Sciences.\nThis research was supported in part by the National Institutes of Health's National Institute of Mental Health and National Institute on Drug Abuse.\nLarsson is also affiliated with \u00d6rebro University in Sweden.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "There was no sensational language.", "answer": 1}, {"article": "Scientists working for Google\u2019s parent company Alphabet have used artificial intelligence to determine a person\u2019s risk of having a heart attack from their retinal scan.\nFurther tests are required before this latest method can be used within a clinical setting.\nThe risk factors include the person\u2019s gender, smoking status, blood pressure and age\u2014estimated to within four years of the patient\u2019s actual age.\nThe method\u2014detailed in a paper published on Monday in the Nature journal Biomedical Engineering\u2014involves analyzing blood vessels in an area of the eye called the retinal fundus.\n\u201cMost cardiovascular risk calculators use some combination of these parameters to identify patients at risk of experiencing either a major cardiovascular event or cardiac-related mortality within a pre-specified time period, such as 10 years,\u201d the paper states.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "This story does not appear to be based on a news release.", "answer": 1}, {"article": "After 78 weeks, they found that patients given bapineuzumab had about a 25 percent reduction in plaque compared with those on placebo.\nThe new study, which only involved 28 patients, is modest fillip.\nThe drug\u2019s developers have since dropped the top dose from large ongoing Phase III trials.\n(Editing by Jon Loades-Carter)\n\u201cIt demonstrated that the drug has an effect on the pathological hallmark of Alzheimer\u2019s disease,\u201d lead researcher Juha Rinne from Finland\u2019s University of Turku told Reuters.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "\u00a0The story does not appear to rely on a news release.", "answer": 1}, {"article": "Androgens, including testosterone, are thought to contribute to the growth and development of prostate cancer.\nThe men in the trial received the ADT drugs for two years.\nMore research will be needed to confirm which men benefit most from taking the drug.\nBecause prostate cancer can progress relatively slowly, the study \u2014 which ran from 1998 to 2003 \u2014 needed an extended follow-up period to be sure of the effects, Shipley said.\nThe study represents an important, if incremental, step for clinicians, noted Dr. William See, chair of the urology department at the Medical College of Wisconsin, who wasn\u2019t involved in the study.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "We didn\u2019t find any evidence of reliance on a news release.", "answer": 1}, {"article": "Many more stroke victims than previously thought can be saved from disability or death if doctors remove blood clots that are choking off circulation to the brain, a new study has shown.\nThe study showed that the time window could be expanded to 16 hours.\nHowever, the findings do not apply to every stroke victim.\nOnly about half the patients who were screened qualified for treatment, known as thrombectomy, which uses a mechanical device to pull clots out of a blood vessel.\n\u201cThese striking results will have an immediate impact and save people from lifelong disability or death,\u201d Dr. Walter J. Koroshetz, director of the National Institute of Neurological Disorders and Stroke, said in a statement.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story does not appear to rely on a news release.", "answer": 1}, {"article": "The California Walnut Commission offices are located at 101 Parkshore Dr., Ste.\nSome study limitations should be considered.\nCWC is an equal opportunity employer and provider.\nshould contact the CWC offices at (916) 922-5888.\nThe CWC is mainly involved in health research and export market development activities.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "The news release does not engage in sensational or unjustifiable language.", "answer": 1}, {"article": "FDNA scientists published a paper in January showing that their algorithm could better identify Down syndrome after being trained with a more diverse set of faces, and Muenke and Linguraru have also published papers this year demonstrating their algorithm\u2019s ability to identify genetic disorders correctly in children across a variety of ethnic backgrounds.\nHowever, the app won\u2019t give clinicians a yes or no answer to the question of, \u201cDoes my patient have a genetic disorder?\u201d\n\nThat\u2019s intentional.\nIt\u2019s a promising preliminary sign.\n\u201cMost practitioners are located in North America and Europe,\u201d Gelbman said.\nThe ultimate goal would be a simple tool that any doctor could use anywhere to get fast results and better diagnose their patients.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story does not rely on a news release.", "answer": 1}, {"article": "Their average age was 69.\nForteo has been in use for the past 16 years, he said.\nThere were no differences among the groups in other serious side effects, such as nausea and heart palpations, Miller said.\n\"Everybody is going to want to know if this is inferior or superior to Forteo,\" she said, adding that this is an early study.\nThere needs to be a large head-to-head trial between Forteo and abaloparatide, she said, to really see which drug is better.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story does not appear to rely on a news release.", "answer": 1}, {"article": "\u201cFor antidepressants in adolescents, this equation will rarely favor prescribing; in younger children, almost never.\u201d\n\nTo be clear, Jureidini believes there is almost never a justification for prescribing antidepressants to children or adolescents.\nThere\u2019s good reason for this.\nA comment attached to the Oxford paper, written by Dr. Jon Jureidini, a child psychiatrist at the Women\u2019s and Children\u2019s Hospital in Adelaide, Australia, goes even further in decrying the use of antidepressants in kids.\nOf course, having an effective intervention once it is recognized would help.\nIf there\u2019s an upside to be found in how ineffective antidepressants likely are for kids, it\u2019s that pharmacological solutions are not the recommended first line of defense, anyway.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story does not appear to rely solely on a news release.", "answer": 1}, {"article": "Compared with the 35 stroke patients who got clot-dissolving medicine alone, the 35 who got the two-pronged treatment were nearly twice as likely to regain some neurological function after three days. Imaging results revealed that for those who got both treatments, 100% of the brain tissue initially affected by a clot had blood flowing to it after 24 hours. Among the subjects who only got alteplase, the median level of restored blood flow was 37%.", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story does not rely on a press release for its content.", "answer": 1}, {"article": "Medical device makers have been working for years to develop a so-called artificial pancreas to deliver insulin to patients with type 1 diabetes, an autoimmune disease in which the body destroys its own ability to make insulin.\n\u201cIt\u2019s a bit like with mobile phones.\nHe said the results were \u201can important stepping stone\u201d toward bringing an artificial pancreas to the commercial market, but predicted several years yet of refinement before it could be used day and night by patients in normal life.\nWhen we started, the technology wasn\u2019t very good and the functionality was limited, and it took a number of generations to move to the device that we have now.\n\u201cThese devices could transform the management of type 1 diabetes, but it is likely to be a gradual process,\u201d Roman Hovorka of Cambridge, who led the research, said in a telephone interview.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "Because there are no independent perspectives in this piece, we can\u2019t be sure of the extent to which it may have been influenced by a news release. ", "answer": 2}, {"article": "Those who reported eating nearly three servings of fruit a day on average had a 25% lower risk of developing breast cancer than those who ate half a serving of fruit.\nThe results also underscore the importance of eating whole fruit, rather than fruit juice.\n\u201cThis study also has an important message for schools and the need to provide students with the opportunity to consume more fruits and vegetables as part of the school meal program.\u201d\n\nFarvid wasn\u2019t able to document a strong relationship between vegetables and lower breast cancer risk, but says that may be because the study wasn\u2019t powered enough to detect an effect.\nMORE: Mediterranean Diet With Olive Oil Linked to Lower Breast Cancer Risk\n\n\u201cThis study underscores the importance of what a young girl eats for her future health,\u201d says Farvid.\nThe findings are among the first to look at how diet during adolescence can affect health later, and highlights the importance of establishing healthy habits from a young age, especially since many of the chronic diseases occur over many years and get rooted early in life.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "This is a close one, since the story is very similar to a release from BMJ. However, the story does appear to include\u00a0quotes from an interview with the lead author.\n\u00a0", "answer": 1}, {"article": "In the increasingly popular \"no-scalpel vasectomy,\" a doctor uses an instrument called a dissecting forceps to poke a very small hole in the skin of the testicles to reach the vas deferens.\nEven the IUD can't stay in place for more than 10 years.\nwhich can be very serious.\"\nThe biggest drawback, Whitaker says, is the need for X-rays three months after the procedure to confirm the fallopian tubes are blocked.\nThey're all temporary means of birth control -- devices you have to keep ingesting or inserting.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "There is no way to know if the story relied on a press release as the sole source of information.", "answer": 2}, {"article": "For example, she says, someone might say, \" 'I find that I'm staying in my room, not answering the phone, not answering texts, not answering emails.'\nIn other words, the intervention had nearly halved the risk of suicide in the six months after discharge.\n(NPR is leaving off his last name to protect his daughter's privacy.)\nHe says she also agreed to use a crisis help line if things escalated.\nThe study, which was published Wednesday in JAMA Psychiatry, included 1,200 patients at five Veterans Affairs hospitals around the country.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story did not appear to rely on the news release.", "answer": 1}, {"article": "Adult brains contain oligodendrocyte progenitor cells (OPCs), which are stem cells that generate myelin-producing cells.\nThe National Center for Advancing Translational Sciences is a distinctly different entity in the research ecosystem.\nAll are approved for use in humans.\nThe NINDS is the nation\u2019s leading funder of research on the brain and nervous system.\nThis work was supported by the NINDS (NS085246, NS030800, NS026543), the New York Stem Cell Foundation and the Myelin Repair Foundation, New York City.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "With the possible exception of the headline \u2014 an issue we\u2019ve already addressed elsewhere in this review \u2014 no hyperbole is evident.\n\u00a0", "answer": 1}, {"article": "Dr. Roger Fielding (Tufts University) is partially supported by the U.S. Department of Agriculture, under agreement No.\nTo see benefits at 48 minutes is encouraging.\nThe work is part of the Lifestyle Interventions and Independence for Elders (LIFE) study.\nof Agriculture.\nMaintaining functional independence for older adults is an important public health issue.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "None here.", "answer": 1}, {"article": "Rosie Dow, Head of Sing with Us at Tenovus Cancer Care and co-author of the research, added: \"This research is so exciting, as it echoes everything all our choir members tell us about how singing has helped them.\nWe have been building a body of evidence over the past six years to show that singing in a choir can have a range of social, emotional and psychological benefits, and now we can see it has biological effects too.\nThe research raises the possibility that singing in choir rehearsals could help to put people in the best possible position to receive treatment, maintain remission and support cancer patients.\nThis research is exciting as it suggests that an activity as simple as singing could reduce some of this stress-induced suppression, helping to improve wellbeing and quality of life amongst patients and put them in the best position to receive treatment.\"\n\u2022 At Tenovus Cancer Care our aims are simple: to help prevent, treat and find a cure for cancer.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "We think the release skated very close but escaped using unjustifiable language. It is important not to overstate findings and raise unrealistic hopes. We thought this sentence with the reference to \u201cpossibility\u201d helped keep the study in perspective:\n\u201cThe research raises the possibility that singing in choir rehearsals could help to put people in the best possible position to receive treatment, maintain remission and support cancer patients.\u201d\nWe agree it raises a possibility, but it is equally possible that the hypothesis is not true.", "answer": 1}, {"article": "Master said each participant was asked to carry an accelerometer to record movements and an iPod Touch loaded with an app that would ping them prompts at intervals during each day to report any symptoms they were feeling. They also completed activity questionnaires and summaries. In addition, they wore a device called an ActiGraph to monitor sleep.", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story contains original quotes from two researchers and so does not appear to solely rely on Penn\u2019s news release. However, it did echo many of its statements.", "answer": 1}, {"article": "The committee's HPV vaccine workgroup is recommending the vaccine be given to girls 11 and 12, and the committee will consider recommendations for females 13 to 26.\nMerck said the drug is not intended to do that.\n\"This is certainly a wonderful, good step in addition to our screening processes\" in helping eradicate cervical cancer, said Dr. Monica Farley, who heads the advisory panel.\nShe is a bacterial infectious disease expert at the Emory University School of Medicine.\nAn agency decision is expected by June 8.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "There is no way to know if the story relied solely on a press release. Only one source is interviewed \u2013 a spokesperson for the American Cancer Society.", "answer": 2}, {"article": "They include people like Danielle Denlein, who, to her total shock, developed a serious heart problem.On October 20, 2008, at 1:50 p.m., Ms. Denlein was driving to a drug store to buy formula for her 5-day-old baby girl.\nIf there are problems, the machine alerts her doctor.\nHalf of them had not been enrolled for remote monitoring and served as a control group.\nIt also gets information on deaths from Medicare.\nSt. Jude recently completed a small study of 40 patients and is starting a large clinical trial.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "\u00a0Does not appear to rely on a news release.", "answer": 1}, {"article": "Citing the results of many small studies, Dr. Bremner said, \u201cThere is good evidence that testosterone administration can improve muscle mass and strength and increase bone density\u201d in men with subnormal levels.\nStill, this study will not answer the question of whether it is safe to use the hormone for years, even decades, which would be necessary to maintain any benefits.\nMen considering treatment should first undergo a full prostate exam and PSA measurement, with periodic prostate checkups during therapy, Dr. Bremner said.\nThen again, this may be a realistic population to study, given that many candidates for hormone therapy are likely to have such health issues.\nAlthough testosterone can cause overgrowth of the prostate, studies have not shown harm to urinary function, Dr. Morgentaler said.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "This article is clearly not based on a news release.", "answer": 1}, {"article": "July 14, 2010 -- An experimental weight loss drug that targets the brain\u2019s hunger center was shown to be safe and effective for helping dieters shed pounds in a two-year study, researchers say.\nThe study appears in the July 15 issue of the New England Journal of Medicine.\nThe company hopes to win FDA approval to market the new drug later this year.\nHe says that all the patients in the study were monitored closely for heart valve irregularities, and no difference was seen in the two treatment groups.\nAll the participants were counseled about diet and exercise.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story does not rely on a news release, but it also doesn\u2019t take the extra effort of having unbiased sources evaluate the drug.", "answer": 1}, {"article": "\"There's no magic in a liter-and-a-half,\" he said.\nThe remaining women served as a control group.\nThis study suggests that it is,\" said Hooton, clinical director of the division of infectious diseases at the University of Miami School of Medicine.\nThey continued their usual fluid intake.\nDr. Susan Bleasdale, medical director of infection control at the University of Illinois at Chicago, said the study \"may be a game changer\" for antibiotic \"stewardship\" programs aimed at reducing inappropriate antibiotic use.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story contained interviews and original information not found in the news release.", "answer": 1}, {"article": "Symptoms can include sadness, insomnia, difficulty concentrating and making decisions, feelings of shame or guilt, as well as difficulty bonding with the baby or thoughts about harming the baby.\nOn average, they spoke about three times.\nBy midway through the study, 37 new moms had received at least one call from a peer counsellor.\nThe new moms found that the conversations helped relieve symptoms.\n\u201cThis study, while small, suggests that peer phone counseling could be a very effective, widespread public health intervention.\u201d\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "Because the story includes interviews with independent experts, we can be sure it did not rely on a news release.", "answer": 1}, {"article": "Among those 40 to 49 who had regular screening, for every 1,000 women tested, 121.2 had a false positive.\n\u201cWe believe the benefits increase with age.\nThe task force said it concluded \u201cwith moderate certainty\u201d that the benefit was moderate in women 50 to 74 and small in women 40 to 49.\n\u201cThe science supports mammography as an important tool in the fight against breast cancer,\u201d said Dr. Michael LeFevre, a former chairman of the task force and a professor of medicine at the University of Missouri.\nFor every 10,000 women screened repeatedly over 10 years, four lives are saved in women 40 to 49; eight in women 50 to 59; 21 in women 60 to 69; and 13 in women 70 to 74, the task force found.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story goes well beyond whatever could be found in a news release on the recommendations.", "answer": 1}, {"article": ".\nThat was what happened to Davis, who had gone to a hospital for a kidney stone.\nHe also knew that the cancer happened to be a spot where the small instruments couldn't reach it, the operation might have to be much more extensive.\nThat was the first thought on Davis' mind as he returned to consciousness in the recovery room, he said.\nInstead, he chose cold.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "There is no way to know if the story relied on a press release as the sole source of information.", "answer": 2}, {"article": "Claudia Kawas, a geriatric neurologist at the University of California, Irvine, said a patient strode into her office soon after the FDA approved the procedure and asked for the \"Alzheimer's test.\" In one hand, he held an article about the approval of Amyvid. In the other, he had a document from a right-to-die group. If the test was positive, he told her, he would get his affairs in order and kill himself within 60 days.", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "Clearly, this was not press-release-driven journalism. Rather, it was a fine piece of entrepeneurial health care journalism.", "answer": 1}, {"article": "The potential use of psilocybin in patients diagnosed with life-threatening diseases comes at a moment when medical care at the end of life is a subject of growing concern among patients and physicians. Research finds it's still common for dying patients to get painful and futile procedures. Palliative and hospice care, both aimed at easing the discomfort of the seriously ill, are growing specialties in American hospitals. An increasing number of patients, meanwhile, are demanding the right to die with a physician's help.", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story does not appear to rely on a news release.", "answer": 1}, {"article": "Autism is a group of complex brain developmental disorders characterized by impairments in social interaction, communication, and stereotypical and repetitive behaviours.\nThere is currently no medical treatment for these problems.\nStudy co-author and co-director of the Brain and Mind Centre, Professor Ian Hickie noted the new results were a critical first advance in the development of medical treatments for the social deficits that characterize autism.\nThe study, led by researchers at the University's Brain and Mind Centre, is thought to be the first evidence of a medical treatment for social impairments in children with autism.\n\"We found that following oxytocin treatment, parents reported their child to be more socially responsive at home, and our own blind independent clinician ratings also supported improved social responsiveness in the therapy rooms of the Brain and Mind Centre,\" he said.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "Other than making claims without backing them up with evidence, we found no unjustifiable language.", "answer": 1}, {"article": "MRI uses a powerful magnetic field and pulses of radiowave energy to create images.\nThe German analysis found only five such studies.\nThe strength of MRI is that it shows tissue configuration.\"\nDr. Ricardo Cury, director of cardiac MRI and CT at Baptist Cardiac & Vascular Institute in Miami and a consultant radiologist at Massachusetts General Hospital, said that the \"meta-analysis demonstrates a knowledge that we have accumulated for the past several years.\"\nIndeed, CT and MRI are not contenders in clinical practice but are used for different reasons to make different assessments, Schoepf said.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story does not appear to rely on a news release.", "answer": 1}, {"article": "In 37 years as a police officer, Edwin Michel coped with a plane crash, a sniper, wildfires and three bullet wounds.\n\nNothing much rattled him until he was diagnosed with prostate cancer in November 2016. His doctor said the cancer wouldn\u2019t kill him but Mr. Michel, now 76 years old, wasn\u2019t entirely reassured. He felt more confident after a genomics test later revealed his prostate cancer was very low risk. The test, known as Oncotype DX, takes a sample from a prostate biopsy and analyzes 17 genes in it to estimate how aggressive...", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story does not appear to rely on a news release.", "answer": 1}, {"article": "Angioplasty, which uses a balloon to open blocked arteries, has been a popular alternative to bypass surgery in part because it brings less trauma to the patient.\nMany who trained to use robots to do coronary bypass run out of patience after three or four procedures, Jeevanandam said, which is why he decided to hire Dr. Sudhir Srivastava, who performed hundreds of robotic bypasses while working at a center in Odessa, Texas.\nSrivastava said it is true that the normal sense of touch is missing from robotic work, and that is a shortcoming, but it can be overcome with practice.\nThe maker of the robotic systems, Intuitive Surgical Inc. of Sunnyvale, Calif., is an enthusiastic backer of the University of Chicago's initiative.\nUsing robotics to bypass major blocked arteries and putting stents in other blocked arteries is gaining some currency, Rabbitt said, although few surgeons have come close to Srivastava's familiarity with the robot.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "A\u00a0University of Chicago issued a press release on the robot surgery program\u00a0and its head, Sudhir Srivastava,\u00a0on July 31. The Chicago Tribune article does not draw on the language or facts in the press release. ", "answer": 1}, {"article": "Trigeminal neuralgia (TN) is a very painful nerve disorder that causes an electrical shock feeling in the face, usually in older people.\nImportantly, the benefit of treatment was strongly driven by improvements in pain and discomfort as well as self-care.\nThe authors, from Cleveland Clinic in the US, say considering radiosurgery earlier on could make a big difference to patients' lives.\nUsing radiosurgery earlier on allows patients to get off the medications, improving their quality of life by allowing them to return to activities they used to do.\"\nThey asked questions about the patients' pain and facial numbness, their health and their ability to take care of themselves.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "There were no major infractions in terms of unjustifiable language, yet unjustifiable conclusions based on the type and size of the study being presented here.", "answer": 1}, {"article": "Breast cancer caused by BRCA mutations is particularly aggressive.\nToby was one of the women researchers from around the country tracked in the study to see how they fared after having this surgery.\nWhile surgical decisions are up to patients, the findings of this study should help them decide what to do, she says.\nPreventable because I can identify the fact that they had a higher risk of getting breast cancer,\" she says.\n(Because she's worried about her health coverage, she doesn't want her last name used.)\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "1clip_filelist.xml\"/>\n\n\n\n \nThe reporter interviewed a researcher, an author of a journal editorial, and a study participant.\n", "answer": 1}, {"article": "(Reuters Health) - Waning eyesight may hasten the pace of cognitive decline in older people, suggests a U.S. study.\nThe good news, Whitson added, is that poor vision is one of the few risk factors for cognitive decline that is potentially modifiable.\n\u201cTaking care of your vision is important in order to maintain good cognitive function,\u201d she said in a telephone interview.\nTo investigate, Zheng\u2019s team followed 2,520 adults for eight years, testing their vision and cognitive status every other year.\n\u201cIf you\u2019re aging without good vision, not only are you giving your brain less stimulation, you might be altering your brain at a structural level,\u201d she said in a phone interview.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "It\u2019s clear there was some original reporting done, and the story didn\u2019t rely excessively on any news release.", "answer": 1}, {"article": "You've seen high-definition televisions. Now some medical centers are marketing their high-definitioncolonoscopes, which they say will detect more pre-cancerous polyps. Several recent studies have found a small benefit to high-definition colonoscopy over the standard variety, but gastroenterologists say physician technique is more important in detecting polyps than equipment.\n\nColonoscopy, a screening test doctors recommend for most people starting at age 50, allows doctors to remove pre-cancerous growths before they become...", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "This story does not rely on a news release.", "answer": 1}, {"article": "The home self-collection test indicated that 12.4 percent of women were infected with high-risk HPV, the self-collection tests used in the clinic found 15.5 of the women had high-risk HPV infection, and the clinician-collected test identified 11.4 percent of the women had high-risk HPV infection.\nSome travel expenses for Des Marais were paid by Hologic, and others have consulted for the company.\nNeither Hologic nor Rovers had input into the research design, analysis or interpretation of results.\nIndividual researchers were supported by the China Scholarship Council.\n\"We didn't miss any of those high-grade cases by conducting home self-collection.\"\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "The release doesn\u2019t indulge in hype or over-selling the findings.", "answer": 1}, {"article": "\"Because cancer cells are different to healthy ones, they produce a different mixture of chemicals.\nTUESDAY, Jan. 31, 2017 (HealthDay News) -- A breath test to detect stomach and esophageal cancers shows promise, researchers say.\n\"At present the only way to diagnose esophageal cancer or stomach cancer is with endoscopy.\nFindings from the study were presented Monday at the European Cancer Congress (ECC).\n\"A breath test could be used as a noninvasive, first-line test to reduce the number of unnecessary endoscopies.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story appears to be based largely, if not solely, on a news release issued by the European Cancer Organization, which organized the conference where the research was presented. See our review of the news release.", "answer": 0}, {"article": "Cigarette smoke causes 90 percent of all cases of lung cancer, which kills 1.2 million people a year globally.\n\u201cInterestingly, current smokers did not show any significant improvements,\u201d they added.\nThey received either Tarceva, a drug sold by Roche and OSI Pharmaceuticals and known generically as erlotinib, or a placebo until they got worse or died.\nFewer than half of all lung cancer patients who do well after a first course of chemotherapy get more treatment, but the Italian group said their study shows this is worth doing.\n\u201cOral iloprost showed promise for preventing lung cancer in former, but not current, smokers in a phase II clinical trial,\u201d they wrote in a summary presented to a meeting of the American Thoracic Society in New Orleans.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "We can\u2019t be sure of the extent to which the story may have relied on a news release.\u00a0 We do know that it didn\u2019t quote any independent sources. ", "answer": 2}, {"article": "Feb. 2, 2011 -- The human papillomavirus (HPV) vaccine can help stave off genital warts in boys and men, according to a new study in the Feb. 3 issue of the New England Journal of Medicine.\nBoth of these vaccines are recommended to prevent cervical cancers.\nThe vaccine is recommended for optional use in boys and men.\nThese vaccines are now on the CDC\u2019s routine childhood vaccine schedule for girls starting at age 9.\nTwo HPV vaccines are now approved by the FDA: Cervarix and Gardasil.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The quotes from several experts demonstrate independent reporting.", "answer": 1}, {"article": "In 2012, a federally funded panel of experts on preventive care concluded there are more risks than benefits to screening American men for prostate cancer with the PSA test. And in April 2017, the U.S. Preventive Services Task Force dumped the decision squarely into the laps of patients and their doctors. Some men between 55 and 69 years of age might well decide to get their PSA checked, the task force said. After hearing the ledger of pros and cons, however, others in that age bracket might just as reasonably skip the screening test, the panel concluded.", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "There are original quotes in the story.", "answer": 1}, {"article": "In patients with age-related macular degeneration - or AMD - the center of the retina responsible for vision deteriorates over time.\nThere's a catch: it's expensive \u2014 about $2,000 per injection \u2014 although Medicare and most insurance companies cover most of it.\nThree months ago, he noticed his vision was distorted.\nIt's not a cure, but it's a blessing for Rochelle Faller.\nBut Daniel is lucky.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "There is no way to know if the story relies on a press release as the sole source of information.", "answer": 2}, {"article": "An infarct, a kind of stroke, happens when the passage of blood is slowed or completely blocked by clotting.\nThe bottom line for dementia is that fish oil may help in the very early stages, but more research must be done to confirm this, he said.\nResearchers will continue to follow the participants in the study and check in on them every year and a half, Scarmeas said.\nIt is possible that the diet protects the brain vessels themselves, irrespective of other problems such as high blood pressure, Scarmeas said.\nIn general, dietary patterns are consistent for at least seven or eight years, Scarmeas said.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "Although there is some language in the story that is very similar to that found in a news release, we rule this satisfactory because an independent expert was quoted, indicating that the story didn\u2019t rely solely or largely on a news release. ", "answer": 1}, {"article": "Asians are at high risk of developing diabetes even at a healthy weight.\nThe expanded criteria include a family history of diabetes, history of gestational diabetes or polycystic ovarian syndrome or non-white race or ethnicity.\nBut there has been little attention focused on this group's most recent diabetes screening guideline.\nBy following this recommendation, 53 percent of patients who had prediabetes or type 2 diabetes would not be screened.\nThis is the first study to report how these expanded screening criteria would perform in practice among a nationally representative sample of U.S. adults.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "There is no inappropriate language with the exception of the use of the term \u201cdysglycemia\u201d to suggest a new disorder encompassing both those with \u201cprediabetes\u201d and type 2 diabetes. This is addressed under the Disease Mongering criteria.", "answer": 1}, {"article": "We've had a lot of migrants from European nations, so they're fair-skinned ... and we do have a very intense sun here,\" Ziman said.\nHowever, she stressed the fact this new test has not undergone clinical trials.\nThe Australian team believe theirs would be the first to detect melanoma.\nThe test could speed up the diagnosis process, saving thousands of lives.\nFor potential sufferers in remote areas, away from skin specialists, diagnosis can be especially tricky, he said, making a simple blood test an easy alternative to identify those at risk.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story does not appear to rely on a press release.", "answer": 1}, {"article": "About the American College of Surgeons\n\nThe American College of Surgeons is a scientific and educational organization of surgeons that was founded in 1913 to raise the standards of surgical practice and improve the quality of care for surgical patients.\n\"We think that it is important to make this information more available to the public.\n\"We found that laparoscopic surgery is associated with significantly lower costs.\nThe College is dedicated to the ethical and competent practice of surgery.\n\"Subsequently, the rate increased, but 15 percent of all anti-reflux operations were still being performed through an open approach in 2013.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "We did not observe any unjustifiable language.", "answer": 1}, {"article": "In an interview, Sakoda said, \"Metformin use was not associated with lung cancer risk when we looked at all patients with diabetes.\nAssiamira Ferrara, Charles Quesenberry Jr., and Laurel Habel, coauthors on this study, have received research funding from Takeda to Kaiser Foundation Research Institute for a study of pioglitazone and cancer and from Sanofi through a subcontract from University of North Carolina to Kaiser Foundation Research Institute for a study of insulin glargine and cancer.\nThis study was funded by the National Institutes of Health.\nAdditional large, well-conducted studies are needed to clarify whether metformin may be used to prevent lung or other cancers, particularly in specific subpopulations, such as nonsmokers.\"\nThe AACR actively communicates with legislators and policymakers about the value of cancer research and related biomedical science in saving lives from cancer.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "The release is cautious in its choice and use of language in explaining the current research.\u00a0 It is troubling, however, that a small aspect of the research\u2019s findings is the main emphasis of the release, while the research paper itself keeps that aspect in proper perspective.", "answer": 1}, {"article": "Still, the study suggests that brain stimulation \"not only just helps patients who haven't been able to recover from depression, but it seems to be associated with the absence of relapses.\nThere are some caveats.\nThe cost of the surgery is about $50,000, she said.\nAnd for now, the research is preliminary, so it's too early to know for sure if the treatment is appropriate to be used for any kind of depression.\nThe new study, which appears online Jan. 2 in the Archives of General Psychiatry, began with 10 patients with depression and seven with bipolar disorder -- a condition that causes severe mood swings and is also known as manic depression.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story does not rely on this press release from Emory University.", "answer": 1}, {"article": "Yet the women with those tumors also experienced a reduction in cancer recurrence from Herceptin, in some cases as great as that in the Her2-positive women.\nIt left some doctors at the conference incredulous and uncertain how to treat their patients.\nBut he said the studies called attention to the inconsistent quality of Her2 testing in many small laboratories.\nSome experts were skeptical, saying the number of patients in the two studies was too small to draw firm conclusions.\nSo better ways are needed to determine who should be treated.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story does not appear to rely on a press release as several sources are cited.", "answer": 1}, {"article": "She said the findings are important because, \"they help us understand why individuals with autism have difficulty with complex behaviors, such as social interaction and language.\nThe research was conducted at Boston Children's Hospital and was published online June 25 in the journal BMC Medicine.\nThe study, conducted by researchers at Harvard University Medical School, looked at the synchronization of brain activity across different brain regions, as measured by EEG.\n\"This reduced functional connectivity in the brain helps us understand impairments associated with autism,\" she added.\nThey found that the two groups had widespread differences in terms of brain connectivity.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story does not rely on a news release.", "answer": 1}, {"article": "Lovaza is an omega-3 drug FDA-approved for the treatment of severe high triglycerides at the dose of 4 milligrams daily.\n\"This represents an example of a personalized approach to breast cancer prevention.\"\nThese findings may help to support future research looking at the direct effect of omega-3 supplementation on breast cancer incidence in obese women.\nNormal-weight women have less inflammation than heavier women, and are therefore less likely to benefit from anti-inflammatory omega-3s, he said.\n\"The finding supports the idea that omega-3s, and specifically DHA, are preferentially protective in obese postmenopausal women,\" Manni said.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "The release does not use any explicitly unjustifiable language. We do have concerns that the release suggests, particularly in the headline, that there\u2019s a method that \u201cmay\u201d reduce breast cancer risk but then fails to provide reasonably expected data to back up the claim.", "answer": 1}, {"article": "Compared to placebo, patients showed significant improvement in mood within 40 minutes of receiving the ketamine infusion, using a common depression rating scale.\nNearly all were unemployed, Zarate and his team note, and two-thirds were on psychiatric disability.\nThose rights would be assigned to his employer, the National Institutes of Health.\nBut, according to Zarate, more research is needed on how to use the drug in the safest and most effective way.\nRight now, medications available for treating either major depression or bipolar illness can take weeks, or even months, to work, notes Dr. Carlos A. Zarate Jr. of the National Institutes of Health in Bethesda, Maryland, one of the researchers on the study.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The quotes from Zarate are fresh \u2013 clearly not from a news release.", "answer": 1}, {"article": "In the study, 15 men and 15 women drank either 17.6 ounces of a beet juice beverage consisting of about three-fourths beet juice and one-fourth apple juice, or a placebo juice.\nThey were then monitored for 24 hours.\nIn this case, Coles says it may be partially explained by the fact that the women in the study tended to be older, and many were on prescription medications, such as oral contraceptives.\nThe results appear in Nutrition Journal.\nThe same procedure was repeated two weeks later, with those who drank the placebo on the first round receiving beetroot juice on the second.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "We could not find a press release associated with this study. The story appears to meet our minimum criteria for original reporting.", "answer": 1}, {"article": "In a first, U.S. trial to test Cuban lung-cancer vaccine\nScientists who weren't involved in the study agreed that it was highly significant.\nSome of the results had been released previously, but not specific details.\nExperts said they will have to see more details before they can determine whether the medication is better used alone or with chemo.\nStill, he said, the approach was not a cure and there is a lot of room for improvement.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story does not appear to rely on a new release.", "answer": 1}, {"article": "Two new devices\u2014one that deflates fat cells, one that destroys them\u2014have just been cleared for \"body contouring\" in doctors' offices by the Food and Drug Administration.\n\nZeltiq grabs onto love handles and belly pouches and freezes the fat cells inside, causing them to self-destruct over several months. Zerona...", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story did not appear to be drawn from a press release from either company.", "answer": 1}, {"article": "Saturated fats can remain a part of a healthy diet, in limited amounts \u2013 but there are two easy ways to help:\n\u2022 Saturated fats should make up 10 percent of total caloric intake daily.\nA new study suggests the answer may be no.\nHow does this translate to what we eat every day?\nBut that\u2019s a misleading association because a variety of illnesses can also cause drop in cholesterol, which is unrelated to diet.\nAll that is known is the participants had a normal cholesterol levels and normal blood pressure.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story does not appear to rely solely on a news release.", "answer": 1}, {"article": "\"The next questions are, 'how do we increase the number of patients who respond?'\n\"The overall survival benefit shown in this study sets a new benchmark for therapeutic strategies for advanced RCC patients in need of a second-line therapy.\"\nThe Breakthrough Therapy designation is intended to expedite the development and review of medicines with early signals of clinical benefit in serious diseases to help ensure patients have access to new therapies as soon as possible.\nPublished online by the New England Journal of Medicine and being presented this week at a Presidential session of the European Cancer Congress (ECC), the findings of CheckMate-025 provide definitive evidence that an immune checkpoint inhibitor is a valid treatment strategy for patients with advanced RCC, and supports a paradigm change in the standard of care treatment, according to the authors.\nFor the first time, an immune checkpoint inhibitor has been proven to increase survival among patients with advanced renal cell carcinoma (RCC), a patient population for whom treatment options are currently limited.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "The language of the release is somewhat hyperbolic given the small magnitude of the benefit. Examples: \u201cbreakthrough\u201d \u2026 \u201cthis is a new way forward\u201d \u2026 \u201cthis study sets a new benchmark for therapeutic strategies for advanced RCC patients\u201d \u2026 \u201cportends paradigm change.\u201d However, the term \u201cbreakthrough\u201d is technically consistent with the FDA designation of nivolumab as a \u201cBreakthrough Therapy.\u201d We\u2019ve been critical of that designation\u00a0because we think it skews patient expectations and may set them up for disappointment. But we\u2019ll give the benefit of the doubt on the rating. We remind readers, as the release does, that the \u201cBreakthrough Therapy designation is intended to expedite the development and review of medicines with early signals of clinical benefit in serious diseases to help ensure patients have access to new therapies as soon as possible.\u201d", "answer": 1}, {"article": "This compared with 1.9 percent using mitoxantrone.\nThe primary endpoint of the so-called Tropic trial was overall survival.\nThe FDA\u2019s review should happen in the third quarter, Sanofi said.\nThe clinical trial results will be presented at the 2010 American Society of Clinical Oncology (ASCO) on June 6.\n\u201cThe development of cabazitaxel is one of many investigational compounds we hope to present to the cancer community in the months and years to come,\u201d Debasish Roychowdhury, Sanofi\u2019s oncology senior vice president, said.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "\u00a0Although we could not find a company press release, all of the info comes from a company spokesperson about results of a study yet to be presented.\u00a0 Is that any different than relying solely or largely on a news release? ", "answer": 0}, {"article": "Both groups went to their V.A.\n\"But this is the first study of its type.\nThe new results are published in JAMA Dermatology.\nNeither the veterans nor the examining dermatologists knew who received 5-FU and who received the placebo.\nHe and colleagues are planning further studies, including one to determine the cost-effectiveness of 5-FU treatment.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "The release does not rely on unjustifiable language.", "answer": 1}, {"article": "The requested URL /usnews/health/articles/070805/13folate.htm was not found on this server.", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "Does not appear to rely on a press release", "answer": 1}, {"article": "Amid a dry spell for breakthrough cancer drugs, recent U.S. approval of Eisai Co.'s Halaven represents some vindication for a small group of researchers who believe, contrary to recent pharmaceutical fashion, that molecules from nature hold promise against hard-to-treat diseases.\n\nThe Food and Drug Administration's approval of Halaven in November for treating late-stage breast cancer was a triumph of chemistry and tenacious research. Its path, extending nearly three decades from the first studies, demonstrates not only potential...", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "", "answer": 1}, {"article": "Of those 40 women, 26 had mutations carrying low to moderate risk of breast or ovarian cancer, eight had mutations associated with Lynch syndrome, which increases colon and ovarian cancer risk, and three had high-risk breast cancer genes.\nEarlier this year, 17 genetic experts argued against testing for a wider panel of breast cancer-related gene mutations until they are proven to be valid and useful in clinical practice (see Reuters story of May 27, 2015 here: reut.rs/1TvOoDf).\nSeveral of the authors of the new paper disclosed that they receive research funding, consult for or are employed by genetic testing companies like Myriad Genetics and Invitae Corporation.\nAnd for many, family testing would be recommended for first-degree relatives, according to the report in JAMA Oncology.\nEven among all appropriate candidates who are sent for genetic testing, only nine percent will test positive for the BRCA mutations, so an additional four percent who have non-BRCA mutations is a significant number, Ellisen said.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story references an interview with the study\u2019s lead author, so we can be sure it went beyond this news release issued about the study.", "answer": 1}, {"article": "\"As soon as you stop the chemo, you feel stripped, and you think, 'Wow, what do I do now?'\nThen, he discovered in one of his own brain scanner experiments that he -- had brain cancer.\n\"\n\nServan-Schreiber did what he knew best -- he hit the books, and was surprised to find studies on how nutrition and exercise might help the body fight cancer -- information doctors never told him.\nHe has penned the best-selling book, \"Anti-Cancer: A New Way of Life,\" about his past and on-going battle, and offers suggestions to fellow cancer patients.\nIn addition, LaPook spoke with several other cancer patients who told him they're left in the dark, too, about how exercise and eating the right foods might help them in their battles against the disease:\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "There is no way to know if the story relied on a press release as the sole source of information. We do know that it relies on only one source \u2013 who\u2019s promoting his book \u2013 and on a network that is cross-promoting its involvement in a cancer telethon. \u00a0", "answer": 2}, {"article": "Mayta-Apaza AC, Pottgen E, De Bodt J, et al.\nHowever, the new study does suggest that Montmorency tart cherries can be added to the list of gut-friendly foods.\nWhile previous studies on Montmorency tart cherries have ranged from heart health and exercise recovery to sleep, this is the first study to explore the potential gut health benefits.\nWhile the dietary intervention was based on a limited number of human volunteers and more research is needed to support these conclusions, the results help build the foundation for future research and suggest Montmorency tart cherries can play a role in positively shaping the microbiome and maintaining gut health.\nThe microbiome has been the focus of multiple studies in recent years due to its potential role in maintaining digestive health, as well as its impact on immunity, heart health, blood sugar control, weight management and even brain health.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "The use of repeated phrases such as: \u201cenhance gut health \u2026 gut-friendly foods \u2026 good bacteria \u2026 shaping the microbiome\u201d perpetuates and reinforces the erroneous notion that scientists have definitively determined which bacteria are good vs bad, and that we can dictate the \u201chealth\u201d of our microbiome by our food choices. To date, there is no research that can unequivocally support these notions.\nThis study does not support such cause-and-effect language or the over-reaching news release headline.", "answer": 0}, {"article": "The U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases has more about hip replacement.\nThe findings are published in the Nov. 28 online edition of Arthritis & Rheumatism.\n\"Joint arthroplasty is successful in relieving the pain and disability caused by hip or knee arthritis,\" study author Dr. Bheeshma Ravi, from the University of Toronto and Women's College Research Institute, said in a journal news release.\n\"While complication rates are low, there are some cases with serious consequences that include infection, joint dislocation, blood clots and even death.\"\nWEDNESDAY, Nov. 28, 2012 (HealthDay News) -- Patients with rheumatoid arthritis are more likely to suffer hip dislocation after hip replacement surgery than those with osteoarthritis, a new study says.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story notes that it is based on a news release. The quote is identified as coming from a release. But the poor quality of the story demonstrates why this sort of news release re-write is of little value to readers.\nNotably, the National Library of Medicine\u2019s MedlinePlus web site posted this story as is, thus tarnishing the site\u2019s claim to provide \u201cTrusted Health Information for You.\u201d\n\u00a0\n\u00a0", "answer": 0}, {"article": "Resveratrol is a naturally occurring compound found in foods such as red grapes, raspberries, dark chocolate and some red wines.\n\"We're not sure how to interpret this finding.\n\"It does appear that resveratrol was able to penetrate the blood brain barrier, which is an important observation.\nThe results, published online today in Neurology, \"are very interesting,\" says the study's principal investigator, R. Scott Turner, MD, PhD, director of the Memory Disorders Program at Georgetown University Medical Center.\nOne outcome in particular was confounding, Turner notes.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "The news release uses appropriate, neutral language and steers clear (for the most part) of sensational wording. The only potential deviation comes from the patient family quote, where the quoted individual talks about wanting to find a \u201ccure.\u201d The release in no way suggests that resveratrol might be such a cure, however we\u2019re not sure that the quotation adds much in the way of value to the release.", "answer": 1}, {"article": "If a pill could prevent teenagers from taking dangerous risks, would you consider it for your children?\n\nI\u2019d be tempted. My skateboard- and bicycle-riding son was hit by a car\u2014twice\u2014when he was a teenager. I would have welcomed anything that could have averted those dreadful phone calls from the emergency room.\n\nWhile some bumps and scares...", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story does not rely on the news release.\n\u00a0", "answer": 1}, {"article": "(image: transmission electron micrograph of Zika virus, NIAID)\n\n\"If we could find a way to specifically target those GSCs that are the source of recurrence, then that might provide an option to prevent recurrence or even a cure,\" says Qin.\nIn addition, the Zika virus was much less efficient at attacking the differentiated, healthy brain cells.\nIn a study published this week in mBio\u00ae, an open-access journal of the American Society for Microbiology, the team shows that a live, attenuated version of the Zika virus could form the basis of a new treatment option for this fatal brain cancer.\nIt enhances laboratory capacity around the globe through training and resources.\nNext, the team will work with clinicians to develop safety tests of the ZIKV-LAV in glioblastoma patients.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "It is too early for the release headline to suggest to that this therapy will be of benefit in human populations and unreasonable to suggest that humans would live longer based on this research.", "answer": 0}, {"article": "The results have not previously been published or presented.\nThere is also a dramatic price difference between the two diagnostic tests.\nThis presentation outlines the results from two recently completed phase III trials (TESEC-05 and -06).\nThe cost of a C-Tb test is to be determined; however, it is expected to be significantly less than an IGRA.\nThe safety profile of C-Tb was acceptable and not different from TST.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "The release does not appear to use any unjustifiable language.", "answer": 1}, {"article": "\u201cBut this is a small study, a proof of concept.\n\u201cWe must bear in mind that this is a pilot study with a small sample,\u201d Anna Fenton, co-editor of Climacteric, said in commentary on the work.\nBut they stressed that the trial was small, so far larger studies are needed to confirm the results.\nThe women\u2019s menopausal symptoms, sexual interest and activity were measured using a standard questionnaire that explores factors such as satisfaction with frequency of sex, vaginal lubrication, orgasm, and sexual partner.\nLONDON (Reuters) - A hormone called DHEA and mostly secreted by the adrenal glands may be able to help women who are going through menopause and could also give them better sex lives, a study found on Tuesday.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The quotes in the story come from the press release issued by the journal (posted here by News Medical).\n\u00a0", "answer": 0}, {"article": "The requested URL /usnews/health/articles/070603/11back.htm was not found on this server.", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story did not appear to rely solely or largely on a news release. ", "answer": 1}, {"article": "For example, insulin resistance, where the body does not use insulin effectively, occurs long before blood sugars reach the level seen in type 2 diabetes.\n\"They also raise the possibility that, in selected individuals, these measurements could identify those at highest risk of developing diabetes so that early preventive measures could be instituted.\"\n\"These findings could provide insight into metabolic pathways that are altered very early in the process leading to diabetes,\" says researcher Thomas Wang, MD, of Massachusetts General Hospital's Cardiovascular Research Center, in a news release.\nMarch 20, 2011 -- Elevated levels of a group of five amino acids may predict the development of diabetes years before any noticeable symptoms occur, according to a new study.\nResearchers found that blood tests that screened for these amino acids accurately predicted risk of type 2 diabetes in otherwise healthy adults as well as in those with traditional risk factors such as obesity.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "It was difficult to find information in the story that was not found in the news release. We give the\u00a0story credit for at least\u00a0acknowledging that its\u00a0one quote came from the news release. \u00a0But overall we think this story leaned too hard on\u00a0the release.\u00a0For example, compare these\u00a0eerie similarities between the story and the news release:\nNote that the key difference is the numbers. Perhaps the author did not see \u201cfour to five times\u201d explicitly in the study itself. We\u00a0couldn\u2019t find it\u00a0either. We did\u00a0find, as the story\u2019s\u00a0author did, the \u201cfive to seven times\u201d result. That result came from the first half of the study, the derivation sample. We wonder if it would have been more balanced to summarize another way. The study itself summarizes the overall results as showing a risk \u201cat least 4 fold higher.\u201d", "answer": 0}, {"article": "New research analyzing more than 22,000 U.S. cases of aortic aneurysm repair is likely to hasten the trend toward more procedures being done with a device called a stent-graft instead of the typical surgery that requires up to eight weeks of recovery.\n\nThe study by doctors at Harvard Medical School and the federal Centers for Medicare and Medicaid Services found the death rate in surgery, 4.8%, was four times that of the 1.2% death rate in placing stent-grafts to seal off the aneurysm. Surgery tended to provide a more permanent...", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "There is no evidence that the story relied solely or largely on a news release.\u00a0 ", "answer": 1}, {"article": "Research on a bacterial toxin first discovered in Adelaide has led to the development a new blood test for the early diagnosis of ovarian cancer - a disease which kills over 1000 Australian women and 150,000 globally each year.\nA paper published this month in Biochemical and Biophysical Research Communications has shown that the new test detected significant levels of the cancer glycan in blood samples from over 90% of women with stage 1 ovarian cancer and in 100% of samples from later stages of the disease, but not in any of the samples from healthy controls.\nThe team has now engineered a harmless portion of the toxin to enhance its specificity for the cancer glycan and used this to detect it in blood samples from women with ovarian cancer.\nThe team is currently seeking scientific and commercial partners to further test the technology with larger numbers of patient samples and to adapt it for mass screening.\nThe new blood test has the potential to dramatically improve early detection of the disease, although it will require further testing before it is available for clinicians.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "As noted above, there is some unjustified language used; especially given the preliminary nature of these findings.\nMost distressing is that a lead author \u2014 who stands to benefit from a pending patent related to the blood test \u2014 claims \u201cour new test is a potential game changer.\u201d\nLikewise, reference to adapting this technology \u201cfor mass screening\u201d is rather premature given this study does not address the specificity/sensitivity of this blood test in screening a large population whose cancer status is unknown.\n(Remember: mass screening implies being able to reliably find cancer in people without symptoms.)", "answer": 0}, {"article": "More women are undergoing genetic testing after a diagnosis of breast cancer, and improvements in both mastectomy and breast-reconstruction techniques have made the option of a double reconstruction less daunting.\nSeveral developments may be driving the trend toward prophylactic mastectomies, experts said.\nThough the researchers had limited information about the patients, Dr. Tuttle suggested that younger women might be choosing the procedure because their cancers tended to be very aggressive, and they had more years ahead of them in which a second cancer might develop.\n\u201cWhat we\u2019re actually seeing is more and more women at the two extremes: either having minimal surgery, a lumpectomy, or having a bilateral mastectomy,\u201d Dr. Tuttle said.\nHe and other experts emphasized that though the removal of the healthy breast sharply reduced the risk of a new cancer developing in that breast \u2014 the risk is not zero because some tissue can remain \u2014 it was the cancer that had already been diagnosed that posed the greatest threat to a patient\u2019s life.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story does not appear to rely on a press release and there are additional sources cited who are not affiliated with the study.", "answer": 1}, {"article": "The FASEB Journal, April 2017, vol.\nThirty-four samples - both domestic and imported - were reviewed.\nThese preliminary results are promising.\nBecause this study was limited to three meals, further research is needed to determine the factors that influenced outcomes.\nThese data corroborate a short-term study in humans reported by Xiao and colleagues at the same meeting supporting further work in humans to provide additional insight into these findings.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "As previously mentioned, the news release did a good job of keeping sensational language in check. The release kept a cautious tone, and made note of caveats and limitations in each study.\u00a0", "answer": 1}, {"article": "These studies have been done with people, but other promising research has only been done with lab animals so far. In one 2009 study in the Journal of Medicinal Food, tart cherries helped fat rats. Not our favorite role models perhaps, but the obese beasties' risk of Type 2 diabetes and heart disease were reduced significantly, and parallel studies are now in the works with members of our own species, says lead author E. Mitchell Seymour: \"There are some interesting and potentially exciting results on the horizon. Stay tuned.\"", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "It\u2019s unclear how much the story may have been affected by this news release from The Cherry Marketing institute.\nBecause more than one researcher was interviewed, we\u2019ll give the story the benefit of the doubt.", "answer": 1}, {"article": "Numerous studies have found no connection between autism and vaccines or thimerosal.\nTeresa Badillo was at the meeting.\nGeier could not be reached for comment despite several attempts by phone.\nHe told one parent he did not plan to comment for this story.\nLupron therapy grew from the mercury camp.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "This story did not rely on a news release.\u00a0 Strong enterprise reporting. ", "answer": 1}, {"article": "The three current recommended approaches for knee arthritis pain are physical therapy, non-steroidal anti-inflammatory drugs such as ibuprofen and naproxen, or the opioid painkiller tramadol.\nCoolief can be repeated if necessary, but it's not a permanent solution.\nBut those didn't help Felicia McCloden, a 65-year-old grandmother from outside of Chicago.\n\"Though patients have a risk of the physician hitting the wrong nerve, that is extremely rare in the hands of an experienced professional\u201d, Amin said.\nThe Answer May Surprise You\n\nIn May, McCloden underwent the Coolief treatment and the result was instant.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story did not appear to rely on the news release.", "answer": 1}, {"article": "April 29, 2016 - A modified surgical technique may provide a simpler approach to the surgical treatment for one type of chronic headache, according to an \"Ideas and Innovations\" paper in the May issue of Plastic and Reconstructive Surgery\u00ae, the official medical journal of the American Society of Plastic Surgeons (ASPS).\nIt's unclear why the three remaining patients didn't have good improvement, although Dr. Peled notes that two of the three had had temporal headaches for decades before surgery.\nHe describes his initial experience with the new approach in 19 patients.\nThe ADRs are traded on the over-the-counter market in the U.S. (WTKWY).\nNone of the patients experienced complications, and there was little or no visible scarring.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "Overall, the news release did not use unjustifiable and sensational language, which is why we give it a Satisfactory rating.", "answer": 1}, {"article": "Schizophrenia is a long-term mental health condition that causes a range of psychological symptoms, ranging from changes in behavior through to hallucinations and delusions.\nThe game, \u201cWizard\u201d, is designed to help so-called episodic memory \u2014 the type of memory needed to remember where you left your keys several hours ago, or to remember a few hours later where you parked your car in a multi-storey car park.\nScientists at Cambridge University said tests on a small number of patients who played the game over four weeks found they had improvements in memory and learning.\nThe researchers said this was important, since lack of motivation is a common feature of schizophrenia.\nLONDON (Reuters) - A \u201cbrain training\u201d iPad game developed in Britain may improve the memory of patients with schizophrenia, helping them in their daily lives at home and at work, researchers said on Monday.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story draws extensively from a Cambridge University news release about the study, including pulling quotes from the lead author directly from the release (without telling readers where the quote came from).", "answer": 0}, {"article": "For men diagnosed with prostate cancer, the decision about how to treat it -- or even whether to treat it -- can be agonizing.\nThe debate whether to even test for it is ongoing.\nBut he\u2019s part of an international consortium that is trying to make that very scenario a practical reality.\nThe next step, he said, is for group members to validate the predictive power of the markers his team found.\n\u201cIf a man has five or six, it increases his chances quite a bit.\u201d\n\nThe research is still in the early stages, so doctors aren\u2019t likely to be using the genetic markers to determine treatment any time soon.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "There\u2019s no evidence that the story relied solely or largely on the Mount Sinai press release.", "answer": 1}, {"article": "\u201cThis is a first step,\u201d he said, \u201cand all these applications will require further work.\u201d But, he added, if the testing is successful, \u201cI think it will be very popular.\u201d\n\nThe idea for second skin originated more than a decade ago when Dr. R. Rox Anderson, a professor of dermatology at Harvard Medical School, was approached by Living Proof, which had been working on a polymer to be used as a hair product.\nWe saw that as a very high bar.\n\u201cWe were looking for safety, spreadability, adherence, and the right kind of mechanical and optical properties.\u201d\n\nThe \u201cskin\u201d can last for more than a day.\n\u201cYou really can\u2019t see it.\nand a scientific founder of Living Proof, started searching for something that would work.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story clearly went far beyond the university\u2019s news release in explaining the research.", "answer": 1}, {"article": "There are several possible reasons that even a carefully devised single study might fail to show an effect that actually exists.\nThe authors acknowledged certain weaknesses in their study.\n\u201cBut here every one of those things fails.\u201d One of Dr. Barrett\u2019s papers on echinacea was included in the analysis.\n\u201cThese results have pushed me toward the idea.\nOther experts also expressed skepticism.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The reporter did a significant amount of original reporting. ", "answer": 1}, {"article": "A colonoscopy isn\u2019t something you get just for giggles. Beyond the obvious unpleasantness, there\u2019s the small but real risk of complications that in rare cases can lead to hospitalization or even death.\n\nThat\u2019s why the American Cancer Society and other groups recommend that people screened for colorectal cancer using a colonoscopy wait a decade in between tests if no polyps or other signs of potential cancer are found. Polyps are slow-growing, and the benefits of being screened more frequently than that don\u2019t seem to outweigh the risks \u2026", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "It\u2019s clear that the story did not rely solely on a news release.", "answer": 1}, {"article": "Cannabidiol, or CBD, is a compound in the cannabis plant that does not contain psychoactive properties that induce a high.\nThis new, randomized, controlled clinical study eliminated those concerns as participants and their physicians did not know if they were on CBD or placebo, say the study authors.\nIn that program, both the researchers and patient's families knew they were receiving CBD, which may have introduced a bias into the results.\nThe new study confirms results from a December 2015 open-label expanded access program led by Dr. Devinsky that reported reductions in seizure frequency.\nJudith Bluvstein, MD, and Daniel Friedman, MD, also served as co-authors at the NYU Langone site involved in the study.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "The release doesn\u2019t rely on unjustifiable language. It inserts needed nuance in several places. For example, it states: \u201cCannabidiol should not be viewed as a panacea for epilepsy, but for patients with especially severe forms who have not responded to numerous medications, these results provide hope that we may soon have another treatment option,\u201d according to the lead researcher.", "answer": 1}, {"article": "The item you've requested, /cgi-bin/article.cgi?f=/n/a/2006/01/17/national/a130050S19.DTL&type=health, was not found.\n\u2022 the item no longer exists, or\n\u2022 there has been an error on the site.\n\nIf you feel the address you entered is correct you can contact us, mentioning the error message received and the item you were trying to reach.\n\nWe apologize for any inconvenience. From here, you can:\n\u2022 use the menu bar above\n\u2022 select an item from our site index below", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "", "answer": 2}, {"article": "Accumulations of neurotoxic beta-amyloid protein can be detected with positron emission tomography, or PET scans, and analysis of cerebrospinal fluid, but these are invasive, inconvenient and costly, making them impractical for routine screening and follow-up evaluation.\nOur goal is to develop a product that is easy to use, affordable and widely accessible.\nShe is the senior leading author of an article in JCI Insight published online Aug. 17.\nClinical trials were approved by Quorum Review, Seattle, Washington, (IRB00003226) and the U.S. Department of Health and Human Services (FWA00019841).\n\"It's exciting to see these studies demonstrating the power of the technology applied to the Alzheimer's field.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "We did not see any unjustifiable language in the release.", "answer": 1}, {"article": "May 14, 2012 -- Acupuncture may allow people with the lung disease COPD (chronic obstructive pulmonary disease) to breathe a bit easier.\nThe study appears online in the Archives of Internal Medicine.\nIn a new study of 68 people with COPD, some got acupuncture, along with their daily medication, for three months.\nOthers got a sham acupuncture treatment, in which the needles did not enter their skin.\nThe study showed that acupuncture may improve stomach function, making it easier for people with COPD to eat a healthy diet and maintain a normal weight.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "There is evidence of original reporting, as the story uses three independent experts. Although the article does not rely on the press release, the release details and quantifies more of the study\u2019s design and results, on which the WebMD story could have done more.", "answer": 1}, {"article": "On weekends, even though hospitals have lower levels of staffing, stroke patients arriving at the hospital may have greater access to equipment and doctors who might be busier during the week than they are on weekends.\nOverall, Kazley added, this study offers \u201cgood news that indicates that the quality of care is similar regardless of when patients present at the hospital for treatment.\nThe current study, she added, shows that \u201chigh quality (stroke) care is available in hospitals on the weekends and weekdays.\u201d In fact, care might even be more aggressive on weekends.\nIndividuals should not wait to seek care for stroke,\u201d Kazley told Reuters Health by email.\n(See Reuters Health report, March 17, 2007).\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story quotes from an email exchange with one of the study researchers and another independent expert. There is no evidence that the story relied on the AMA\u00a0press release about the study.", "answer": 1}, {"article": "Professor Marianne Thoresen said: \"Even if we account for a lesser severity of perinatal asphyxia, our research has shown that therapeutic hypothermia reduces the number of children who develop epilepsy later in childhood.\nThe research was funded by Sparks UK; University of Bristol's Alumni Foundation; The Laerdal Foundation for Acute Medicine, Norway; University of Oslo, and a private donation.\nThe research team has developed and delivered cooling treatment, known as therapeutic hypothermia, for newborns who suffer lack of oxygen during birth.\nThe study has been led by Marianne Thoresen, Professor of Neonatal Neuroscience, from the Bristol Medical School: Translational Health Sciences at the University of Bristol.\nThe patients' cognitive performance, life quality and life expectancy is also affected by having the condition.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "No unjustifiable language here.", "answer": 1}, {"article": "Surgery is considered by some to be the most definitive treatment, and there is evidence from other studies that it has better long-term cancer outcomes than radiation for higher-risk cancers, but it has more sexual and urinary side effects than radiation.\n\u201cIt is best to avoid treatment if you have a prostate cancer that is safe to observe.\n- None of the treatments had an impact on general quality of life, such as the ability to do activities of daily living, emotional health and energy or vitality.\n\u201cPatients who were treated with surgery or radiation had side effects, while those who were managed with active surveillance, for the most part, did quite well,\u201d Barocas said.\nResearch reported in this article was partially funded through a Patient-Centered Outcomes Research Institute (PCORI) award CE12-11-4667.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "We found no unjustifiable language.", "answer": 1}, {"article": "Developed in the laboratory of UHN transplant surgeon Dr. Markus Selzner, with the help of UHN transplant surgeons Drs.\nThe aim was to enhance kidney function, minimize injury and avoid a \u201csleepy kidney\u201d from an extended criteria kidney.\nHe was able to get up and walk two day after his transplant.\n\u201cIt is a champion!\u201d says an elated Dr. Selzner, who has done about 500 kidney transplants in the past 14 years.\nThe scope of research and complexity of cases at Toronto General Hospital have made it a national and international source for discovery, education and patient care.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "The release didn\u2019t contain unjustifiable language.", "answer": 1}, {"article": "Such regular use of low-dose aspirin reduced the risk by 20 percent of estrogen or progesterone receptor positive, HER2 negative breast cancer, which is the most common breast cancer subtype.\nThe team of researchers chose to focus on low-dose \"baby\" aspirin, because not only is it inexpensive and readily available as potential means of prevention, but because there are already a lot of people already taking it for prevention of other diseases such as heart disease and even colon cancer.\n\"We did not by and large find associations with the other pain medications like ibuprofen and acetaminophen.\nWe also did not find associations with regular aspirin since this type of medication is taken sporadically for headaches or other pain, and not daily for prevention of cardiovascular disease.\"\nNow that we have some data separating low-dose from higher-dose aspirin, more detailed research can be undertaken to understand the full value of low-dose aspirin for breast cancer prevention,\" said Clarke.\"\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "The release doesn\u2019t rely on overtly sensational terms like \u201cbreakthrough\u201d or \u201ccure.\u201d\nWe\u2019ve already commented on the inappropriate causal language such as found in the headline which states \u201cregular use of aspirin can lower risk of breast cancer for women\u201d and in the first sentence which claims the study \u201cfound that the use of low-dose aspirin (81mg) reduces the risk of breast cancer in women who are part of the California\u2019s Teacher\u2019s Study.\u201d The study found a correlation between those two things, but that\u2019s all.", "answer": 1}, {"article": "Obesity is associated with heart disease, stroke, diabetes and some cancers, and researchers estimate that it is the second-leading cause of preventable death, after tobacco use.\nDr. Sharaiha did not have any disclosures for DDW research.\n\"Our research -- the first to compare these treatments -- demonstrates that endoscopic sleeve gastroplasty is safe and effective in helping patients lead healthier lives.\nIt's less invasive than surgery and helps them reach their health goals.\"\nIt should be considered as another tool available to clinicians and patients in the fight against obesity.\"\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "The release uses fairly measured language.\nAlthough it doesn\u2019t rise to the occasion of sensationalism, we do have concerns over the\u00a0use of the term \u201cnon-surgical\u201d to describe a\u00a0procedure that certainly sounds like surgery. If it walks and quacks like a duck\u2026.", "answer": 1}, {"article": "When nicotine enters the body, it binds to the same receptors in the brain that acetylcholine binds to, resulting in smoking's rewarding and reinforcement effects.\nSchmidt had successfully employed such a model with other addictive substances like cocaine.\nIn other words, the preclinical data informed the clinical study and vice versa.\nOnce the trial reaches that number, she'll dig into overall quit data.\nAt Penn's Center for Interdisciplinary Research on Nicotine Addiction, work on smoking cessation has been ongoing since 2001.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "There was no reliance on unjustifiable language.", "answer": 1}, {"article": "\"Our thinking is similar to how you might approach a battle against two enemies,\" said Dr. Soran.\nThe study was selected for the society's \"Best of ASCO,\" an effort to condense the research \"most relevant and significant to oncology\" into a two-day program to increase global access to cutting-edge science.\nThis research was primarily funded by the Turkish Federation of Societies for Breast Diseases.\nThe study received scientific advisement from UPMC and assistance with statistical analysis from epidemiologists at the University of Pittsburgh Graduate School of Public Health.\nDr. Soran began the trial in 2007, ultimately recruiting a total of 274 women newly diagnosed with stage IV breast cancer from 25 institutions.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "The headline and quote in the text about \u201cchanging the standard of care\u201d for breast cancer treatment was unjustifiable given the size of the trial and the fact that the findings have yet to undergo peer review.", "answer": 0}, {"article": "Psoriasis is a skin condition that causes patches of skin redness and flaking.\nPatients with Crohn\u2019s disease should not use Siliq.\n\"Patients and their health care providers should discuss the benefits and risks of Siliq before considering treatment.\"\nPatients with new or worsening symptoms of depression or suicidality should be referred to a mental health professional, as appropriate.\nBecause of the observed risk of suicidal ideation and behavior, the labeling for Siliq includes a Boxed Warning and the drug is only available through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS) called the Siliq REMS Program.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "The news release does not include unjustifiable, sensational language.", "answer": 1}, {"article": "Parkinson\u2019s disease is a progressive neurological disease that causes symptoms including muscle tremors, shaking, and stiffness.\nThis was an observational study and therefore can\u2019t establish cause and effect.\nThis study will be presented at a medical conference.\nThe findings should be considered preliminary as they have not yet undergone the \"peer review\" process, in which outside experts scrutinize the data prior to publication in a medical journal.\nNor is it clear why the results differed for men and women.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story discloses that its only quote comes from a news release.", "answer": 0}, {"article": "Platelets, the blood cells that promote clotting, contain hundreds of proteins, called growth factors, that are important in repairing injuries.\nThe remaining tear was quite small.\nBased on my experience with it, I think they are right.\nAfter that, the pain stopped.\nThe tear was completely gone.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "This story does not rely on a news release.\n\u00a0", "answer": 1}, {"article": "Ohio\u2019s roads stink. Here are 5 options to fix them\n\nNobody likes paying more. But it turns out, if we want our roads to improve, we might have to.", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "There does not appear to be a press release linked to this story. ", "answer": 2}, {"article": "In Alzheimer\u2019s disease, this area of the brain is affected early on, when signs of dementia begin to appear.\nThe research was published in the New England Journal of Medicine.\n\u201cAlthough the current evidence is preliminary, is based on small samples and requires replication, the potential application of deep-brain stimulation in amnestic disorders is enticing,\u201d Black wrote.\nDr. Sandra Black, a brain researcher at the University of Toronto who wrote an editorial on the current study, said the findings could have implications for early stage Alzheimer\u2019s disease if tests were developed to identify this process early through imaging or genomics.\nThe team used this opportunity to see how stimulating the brain affects memory.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "This story includes direct quotes from an interview with an author of the researcher report so it\u2019s clear that it did not rely solely on a news release.", "answer": 1}, {"article": "However, contrary to the popularly held belief that a greater number of concussions are linked to CTE , no connection was found between levels of CCL11 and reported number of concussions.\nAn early step in the right direction\n\nMcKee also cautioned that this is still early research.\n\"This may be one of the abnormalities [of the disease], but it may take 2-3 to be useful to diagnose CTE,\" said McKee.\nHowever, there is a potential bias in that study, as relatives of these players may have submitted their brains for diagnosis due to clinical symptoms noticed while the players were alive.\n\"This is something new,\" said Dr. Ann McKee , a neuropathologist and senior author of the studyMcKee has performed many of the high profile diagnoses of CTE among former pro-football players and is director of the Boston University CTE Center.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "Because the story uses a word-for-word quote by one of the researchers from the news release \u2014 without disclosing the quote came from a news release \u2014 the story rates Not Satisfactory on this criterion.", "answer": 0}, {"article": "A 2007 study of Chinese women in Shanghai found that middle-aged women who ate large amounts of white rice and other refined carbohydrates were also at increased risk for diabetes compared to their peers who ate less.\nThe study, which was published in The Archives of Internal Medicine and used data from two Harvard nurses\u2019 health studies and a separate study of health professionals, isn\u2019t the first to point a finger at foods like white rice as a culprit in Type 2 diabetes.\nBut, Dr. Sun said, there were many possible explanations for why brown rice eaters are at lower risk for Type 2 diabetes.\n\u201cThe bottom line is we showed evidence that increased consumption of white rice \u2013 even at this low level of intake \u2014 is still associated with increased risk,\u201d said Dr. Sun, who was at the Harvard School of Public Health when the study was done.\nBut the Harvard study is one of the first to distinguish between brown rice and white rice consumption in the United States, where rice is not a staple food and relatively little is eaten overall, said Dr. Qi Sun, an instructor in medicine at Brigham and Women\u2019s Hospital, which is affiliated with Harvard Medical School.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "Not\u00a0 applicable because we can\u2019t be sure of the extent to which the story was influenced by a Harvard news release.\u00a0 We are sure that the story didn\u2019t quote any independent sources \u2013 just\u00a0 the study author.\u00a0", "answer": 2}, {"article": ".\nThe data review did not look at any health outcomes associated with pasta consumption except for the ones specified below.\nAnd now, even more good news: new research shows that pasta consumption in children and adolescents is associated with a better diet quality than that of children who do not eat pasta.\nThe research, \"Pasta Consumption in American Children and Adolescents is Associated with Greater Daily Intake of Shortfall Nutrients as Defined by the 2015 Dietary Guidelines, Improved Diet Quality and Lower Added Sugar Intake,\" was conducted by Nutritional Strategies, Inc. on behalf of the National Pasta Association.\nFrom the analysis, researchers identified a number of key positive nutritional dietary patterns associated with children and adolescents who eat pasta as part of their diet compared to those who don't eat pasta.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "The release does not rely on sensational language. However, we think the headline language goes overboard based on the scant evidence provided in the release.\n\u201cChildren and adolescents who eat pasta have better overall diet quality new research shows\u201d seems an exaggeration based on what is offered in the release. The release merely says that a few vitamins and nutrients were at higher levels in the pasta-eating children. It does not guarantee their diets are of overall better quality.", "answer": 1}, {"article": "A new pilot study led by McLean Hospital's Ipsit Vahia, MD, medical director of Geriatric Psychiatry Outpatient Services at McLean Hospital, suggests that the use of tablet computers is both a safe and a potentially effective approach to managing agitation among patients with dementia.\nHe became more interactive.\nThese significant improvements are a clear testament of the tablet's potential as a clinical tool.\"\nResearchers loaded a menu of 70 apps onto the tablets for the study.\n\"The biggest advantage is versatility,\" said Vahia.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "The release doesn\u2019t rely on unjustifiable, sensational language.", "answer": 1}, {"article": "Researchers found that each picomolar increase in blood vitamin B12 level was associated with a 2% reduction in the risk of Alzheimer's disease among the elderly.\nBlood levels of folate, another nutrient believed to lower homocysteine levels, were not linked to Alzheimer's disease risk.\nThe seven-year study followed 271 Finnish people ages 65 to 79 who did not have any symptoms of Alzheimer's disease at the start of the study.\nDuring the study, published in Neurology, 17 people developed Alzheimer\u2019s disease.\n\u201cLow levels of vitamin B12 are surprisingly common in the elderly.\"\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "", "answer": 0}, {"article": "Once a woman hits puberty the number drops to 300,000 and by age 30 the amount decreases by 90 percent.\nTurns out there\u2019s a simple blood test that could tell her.\nFor Alyssa Gold, the AMH test was a wakeup call.\nThe test doesn\u2019t measure the quality of the eggs and it\u2019s not a guarantee of fertility.\nAt her regular gynecology visit, Gold took the AMH test and received news she didn\u2019t wanted to hear but it helped her take the next right step for her.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story appears to be original work and not from a news release from any particular institution.", "answer": 1}, {"article": "Studies have found that runners have significantly higher injury rates than walkers (one study found that young men who run or jog had a 25 percent higher risk of injuries than walkers), and that ultramarathoners are at an even greater risk.\nIn many ways, Sarah is a perfect case study in how to think about the benefits and risks of running versus walking.\nAll this research, while illuminating, didn\u2019t offer up any clear conclusions on whether running or walking was better for you overall.\nI wanted to see what the highest-quality evidence \u2014 trials and reviews are the gold standard \u2014 said about the relative risks and benefits of these two forms of exercise.\nSo the answer to the running versus walking question will probably vary from person to person.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story is not reliant on a news release. The author clearly put significant time and effort into doing the background research needed to answer the question she began with, which was what the scientific research says about the benefits and risks of walking versus running for exercise.", "answer": 1}, {"article": "Anticipating wide interest in the psilocybin research from scientists, clinicians and the public, the journal solicited 11 commentaries to be co-published with the study results written by luminaries in psychiatry, palliative care and drug regulation, including two past presidents of the American Psychiatric Association, a past president of the European College of Neuropsychopharmacology, the former deputy director of the U.S. Office of National Drug Control Policy, and the former head of the U.K.\nThe researchers cautioned that the drug was given in tightly controlled conditions in the presence of two clinically trained monitors and said they do not recommend use of the compound outside of such a research or patient care setting.\nBoth studies are published in the Journal of Psychopharmacology on Dec. 1.\nAdditional authors included Matthew Johnson, Michael Carducci, Annie Umbricht, William Richards, Brian Richards, Mary Cosimano and Margaret Klinedinst, all of The Johns Hopkins University.\nThe study was funded by grants from the Heffter Research Institute, the RiverStyx Foundation, William Linton, the Betsy Gordon Foundation, the McCormick family, the Fetzer Institute, George Goldsmith, Ekaterina Malievskaia and the National Institute on Drug Abuse (R01DA03889).\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "The release refrains from bombastic language, offers meaningful detail, and is written in clear, understandable language. We particularly liked that the release states up front that this was a small, and double-blind, study. We also liked the note that \u201cthe drug was given in tightly controlled conditions in the presence of two clinically trained monitors and [researchers] said they do not recommend use of the compound outside of such a research or patient care setting.\u201d Well done.", "answer": 1}, {"article": "Rhesus monkeys and rats performed just as well on memory and attention tasks shortly after being administered DORA-22 as they did on an inactive placebo.\nThat means, theoretically, fewer side effects and perhaps less of a tendency to be habit forming, Thorpy explained.\nAnd will they change the quality of sleep in any way?\nUslaner is director of In Vivo Pharmacology at Merck & Co., which funded the study.\nThose questions will only be answered with more testing and use in humans, he said.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The comments from the two unaffiliated experts demonstrates the story did not rely solely on a press release.", "answer": 1}, {"article": "The liquid is called silver diamine fluoride, or S.D.F.\nNobody looks forward to having a cavity drilled and filled by a dentist.\nNow there\u2019s an alternative: an antimicrobial liquid that can be brushed on cavities to stop tooth decay \u2014 painlessly.\nIt\u2019s been used for decades in Japan, but it\u2019s been available in the United States, under the brand name Advantage Arrest, for just about a year.\nBut studies show it can halt the progression of cavities and prevent them, and dentists are increasingly using it off-label for those purposes.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story doesn\u2019t appear to be based on a news release. And even if it were, its use of independent sources goes well beyond what would have appeared in any news release.", "answer": 1}, {"article": "Around the world, 21 million people have type 1 diabetes.\nGrowing islets will \u201csignificantly increase the number of patients who can receive the treatment,\u201d Keith Thompson, CGT\u2019s chief executive, told the World Stem Cells and Regenerative Medicine congress in London on Wednesday.\nInsulin shots could become a thing of the past for type 1 diabetes patients thanks to a technology being developed by Cell and Gene Therapy Catapult, a London-based not-for-profit organisation, and Aberdeen University.\nJohn Casey, consultant transplant surgeon at the Royal Infirmary of Edinburgh and lead clinician for the islet transplantation programme in Scotland, said: \u201cIslet transplantation can transform the lives of patients with type 1 diabetes, and in some cases can result in long-term freedom from insulin injections with excellent glucose control.\u201d\nThe pre-clinical results have encouraged CGT and Aberdeen University to create a spin-out company, called Islexa.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The news story uses direct passages from the news release,\u00a0without citing the release.\nFor example, this quote was in both the story and the news release:\n\u201cDonated islets are already effectively treating severe cases of type 1 diabetes. Having a hugely expanded supply of lab-grown islets will enable us to significantly extend this established clinical treatment.\u201d\nAs well as this one:\n\u201cIslet transplantation can transform the lives of patients with type I diabetes, and in some cases can result in long term freedom from insulin injections with excellent glucose control.\u201d\n\u00a0", "answer": 0}, {"article": "\"Aspirin is easy to take and much less expensive,\" Hallstrom says.\nThe new U-M study suggests patients may be adequately protected if they take aspirin alone from day one.\nThe study suggests most patients can have just aspirin without increasing the risk for venous thromboembolism, but doctors need to consider factors such as a patient's history of clots, obesity and ability to mobilize after surgery when determining the best measure for clot prevention, Hallstrom adds.\nA recent Canadian study looked at the issue, but the analysis had a caveat: Each of the more than 3,400 clinical trial patients received rivaroxaban the first five days after surgery.\nBased on the experience of 41,537 Michigan patients undergoing knee replacement, the study may further the debate about the routine use of aspirin for clot prevention.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "Although the release paints a rather rosy and benign image of \u201cgood old aspirin,\u201d the release is clear that this study found that there was no statistical difference in outcomes between patients taking aspirin versus anticoagulant drugs\u2026and it pointed out that doctors need to consider a patient\u2019s history of blood clots, obesity and other factors.", "answer": 1}, {"article": "High blood pressure increases the risk for heart attack, stroke and kidney problems.\nThe finding stems from a study of 700 people, who averaged 56 years old.\nAll had high blood pressure.\nShe's a researcher with the George Institute for Global Health at the University of New South Wales in Sydney, Australia.\nThe rate of side effects was no greater among those who took the three-in-one pill than among the usual care group.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story is based entirely on information from a news release.", "answer": 0}, {"article": "Normally it's the very old or very young that die from flu, but every year there are deaths from influenza A,\" said Gilbert.\nThe vaccine would be an important step in treating seasonal flu, not just pandemics.\nLondon, England (CNN) -- Researchers hope a new treatment developed in the United Kingdom will prove vital in controlling future flu pandemics such as H1N1 (swine) flu, bird flu as well as ending the need for annual flu jabs.\nThe initial results are positive, says Peter Palese, professor and chair of microbiology at Mount Sinai School of Medicine, New York, but more research is needed before the new treatment is approved.\nThe results, say Gilbert, are important in developing a new form of protection that researchers hope could spell the end of flu vaccination supply problems.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "", "answer": 1}, {"article": "About two-thirds of breast cancers are hormone sensitive.\nApproval as an initial treatment likely would boost that sharply.\nThe British pharmaceutical company's Tykerb was approved here two years ago as part of a treatment for most women with advanced breast cancer that wasn't stopped after chemotherapy and other drugs.\nTykerb had sales of $189 million last year.\nIt targets cancer cells more than healthy ones, Roychowdhury said.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "We can\u2019t be sure the extent to which the story may have relied on a news release.\u00a0 We do know that the only source quoted in the story was from the drugmaker. ", "answer": 2}, {"article": "Recent research indicates that vitamins C, E and zinc can help vision.\n\u201cThis makes sense, but we\u2019ll see if it holds up in future studies.\u201d\n\nFuture studies should look at the habits, activities and nutrition that affect lifestyle and glaucoma risks, said Idan Hecht of Tel-Aviv University in Israel, who wasn\u2019t involved in the research.\nIn this group, Coleman\u2019s team found that just over 5 percent, 82 people, had glaucoma.\n\u201cGlaucoma can lead to blindness, and it would be great if it could be prevented because there is no cure,\u201d said lead author Dr. Anne Coleman of the University of California, Los Angeles.\n\u201cIn the past few years, there has been a tremendous increase in interest, and subsequently research, into the ways lifestyle changes can influence diseases,\u201d Hecht told Reuters Health by email.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story does not appear to rely solely on the news release. It quotes two independent sources not affiliated with the study.", "answer": 1}, {"article": "New Rochelle, NY, September 25, 2017--A phase 3 study of children ages 6-12 years with attention deficit/hyperactivity disorder (ADHD) has shown that a delayed-release, long-acting formulation of the stimulant methylphenidate, when taken in the evening, led to significant improvement in ADHD symptoms and functional impairment first thing the next morning, compared to a placebo.\nThe article is available free on the Journal of Child and Adolescent Psychopharmacology website.\nA complete list of the firm's 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website: http://www.\nThe Journal is dedicated to child and adolescent psychiatry and behavioral pediatrics, covering clinical and biological aspects of child and adolescent psychopharmacology and developmental neurobiology.\n.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "No unjustifiable language here.", "answer": 1}, {"article": "In a third type of weight-loss procedure, known as sleeve gastrectomy, surgeons remove part of the stomach.\nMore of those undergoing lap-banding, however, needed repeat surgeries (13 percent vs. 2 percent).\nMore people in the bypass group had complications right after the surgery.\nAn editorial accompanying the studies noted the results should be interpreted with caution since longer-term data is not yet available.\nAnd certain procedures may still be preferable for certain patient populations, added Roslin, such as bands for patients with lower BMI who don't have so many metabolic challenges.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The\u00a0reporter seems to\u00a0have contacted two expert sources, although only one is quoted directly. There\u2019s no evidence that anything was taken directly from a press release.\u00a0A close call, but we\u2019re fairly confident in the level of independent reporting done here, so we\u2019ll award a satisfactory.", "answer": 1}, {"article": "A new study shows women who drank the equivalent of a beer or small glass of wine each day were less likely to develop chronic diseases like heart disease, cancer, and diabetes as they got older compared to nondrinkers or those who drink four or more drinks at one time.\nSept. 6, 2011 -- \"A drink a day keeps disease away\" may be the new motto for middle-age women hoping to age gracefully.\nResearchers then analyzed health status information collected after the women turned 70.\nIn the study, researchers looked at the effects of drinking alcohol at midlife on the risk of diseases commonly associated with aging in a group of 13,894 women enrolled in the Nurses' Health Study.\nThe women filled out questionnaires about what they ate and drank at midlife, about age 58.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story didn\u2019t lift anything direct from a press release about the study. Since there are no independent perspectives provided, however, we can\u2019t say for certain how much this story relied on the release. We\u2019ll call it not applicable.", "answer": 2}, {"article": "Surgery for a painful, common back condition known as spinal stenosis resulted in significantly reduced back pain and better physical function than treatment with drugs and physical therapy, according to the latest findings from a large federally funded research effort.\n\nThe results from the Spine Patient Outcomes Research Trial, or Sport, echo findings it reported last April involving degenerative spondylolisthesis, another common spinal problem. A separate, earlier report from the same study found nonsurgical treatment for...", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "By pure word count, fully a third of the text was borrowed verbatim from a press release.\u00a0 169 of the 490 words in the story \u2013 or 34% \u2013 were identical to the phrases found in a Rush University Medical Center news release found on the Newswise online service \u2013 one used commonly by journalists. This is unacceptable in a high school journalism class \u2013 much less in the Wall Street Journal.\u00a0 ", "answer": 0}, {"article": "This signal is passed to a computer that decodes it, and the resulting instruction is then sent to a sleeve he wears on his forearm that stimulates the muscles that move his wrist and fingers.\nThat's why the device requires training every time Burkhart uses it.\nThe setup currently requires a 10\u201315-minute training period at the beginning of every session.\nDetails of the system that allows him to do this, developed by scientists at Ohio State University and Battelle Memorial Institute, are published in the journal Nature today.\n\"The machine is actually learning, and Ian is learning how to refine his thought patterns,\" Chad Bouton, lead author on the paper, said in a press briefing.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story includes comments from independent sources and does not rely solely on a news release.\n\u00a0", "answer": 1}, {"article": "Paul Delios of Saugus, Mass.\nHutcher says it's now about one in 1,000, which makes it less deadly than most major surgeries.\nDr. Hutcher says the operation itself can take type 2 diabetes - which has ballooned in this country - and throw it into complete remission.\nDr. David Cummings, an expert on appetite at the University of Washington, says as a rule these patients end up just one third lighter.\nDespite the increase in obesity, only a small number of people have had the gastric bypass operation.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "There is no evidence the report is based on a press release. \nMany previous news reports have been done on the link between the surgery and reduced incidence of diabetes independent of weight loss, however. ", "answer": 1}, {"article": "As an adult, she faithfully performed facial exercises purported to tighten the area under the chin.\n\u201cIt was receding.\u201d\nShe stood ramrod-straight, head held high, to make the bulge less apparent.\nNothing worked.\n\u201cI was cute as button \u2014 and there was my double chin,\u201d she said.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story is full of independent reporting.", "answer": 1}, {"article": "American veterans coping with PTSD are traveling to lodges in the Amazon that offer ayahuasca, a hallucinogenic brew. Some say it has helped them manage emotional trauma from war, but others say it\u2019s not worth the journey. Photo: Ryan Dube/WSJ\n\nAfter surviving firefights and a roadside bomb in Afghanistan, U.S. Army veteran Asa Barrett tried antidepressant drugs and therapy to overcome depression and bouts of anger. Nothing worked.\n\nBut then, like many other foreigners, he journeyed to Peru\u2019s remote Amazonian jungle to drink ayahuasca, a centuries-old, sacred indigenous brew that some Western scientists think can help to heal psychological traumas.", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "This story does not rely on a news release.", "answer": 1}, {"article": "Asked if he's suggesting that it's some kind of a rejuvenation drug that would turn a 70-year-old into a 35-year-old, Westphal tells Safer, \"That might be pretty hard to do.\nIf they're right, we all may soon be taking a pill that could give us an extra decade or two of healthy old age.\nEveryone from plastic surgeons to your friendly snake oil salesman have been promising a ticket to eternal youth for some time, so the prospect of a prescription pill based on red wine that could trigger a longevity gene sounds too good to be true.\nBut I think if we're on a train heading one direction, we can slow down that train.\n\"The important news here is not that we'd found something in red wine.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "There is no way to know if the story relied on a press release.", "answer": 2}, {"article": "Fluctuating levels of levodopa result in erratic periods of muscular control and involuntary movements throughout the day, disrupting activity at least half a dozen times a day.\nThe company\u2019s shares were up 30.9 percent at $18.84 after the bell on Thursday.\nThe long-acting therapy is taken once-daily at bedtime.\nAn estimated 90 percent of levodopa-treated patients, about 200,000 people in the United States, suffer from LID, the company said.\nWith Gocovri, which targets both dyskinesia and off time, patients will be able to reclaim about 3.6 hours of their day, CEO Gregory Went said in an interview ahead of the decision.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "While it didn\u2019t provide much beyond the drug company\u2019s news release, it didn\u2019t appear to rely solely on the release, as there were some statements from an interview.", "answer": 1}, {"article": "TUHS neither provides nor controls the provision of health care.\nTheir superior performance suggested a successful reversal of memory deficiency.\nThe study is especially exciting because zileuton is already approved by the Food and Drug Administration for the treatment of asthma.\n\"This is an old drug for a new disease,\" he added.\n\"The research could soon be translated to the clinic, to human patients with Alzheimer's disease.\"\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "Although parts of the release are cautious in describing what the drug can do, the use of words like \u201cbreakthrough\u201d and \u201cespecially exciting\u201d appear unwarranted.", "answer": 0}, {"article": "Dr. Heather Hayes, Director of Food Innovation with Devenish, said:\n\n\"Offering birds a natural and sustainable source of omega-3 PUFA is good for the bird and good for the consumer.\n\"Therefore, in this project we studied the recently developed alternatives to oily fish or supplementation, namely chicken meat and eggs, naturally enriched with sustainable algae-based omega-3 PUFA.\n\"We worked closely with Moy Park, Waitrose and the Royal College of Surgeons in Ireland, to deliver an innovative, nutrient-rich food, that increases omega-3 levels in consumers, naturally.\n\"This science has demonstrated the importance of food nutrients to promote good health and prevent ill health.\nWe are also focusing our research efforts on producing sustainable and nutrient rich pork, beef and milk, with scientifically proven health claims.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "The headline on the release claims the new feed is \u201clikely to reduce risk of heart attack, stroke, dementia and depression,\u201d which is a claim not supported by what the release offers. And as we\u2019ve mentioned before,\u00a0the release also touts the study as \u201ca world-first clinical trial,\u201d a descriptor that we don\u2019t perceive as being accurate.", "answer": 0}, {"article": "In one patient, the assay was able to show the presence of three different mutations.\nIn contrast, molecular tests like the one we have developed will enable patients to be monitored at every visit, and thus have the potential for quickly tracking cancer growth and spread.\n\"For monitoring patient tumors, only a handful of blood tests are available which are limited to only several types of cancers.\nAccording to the report in The Journal of Molecular Diagnostics, this highly sensitive test has the potential to be personalized to recognize mutations unique to any individual cancer.\nNearly all cancer patients require monitoring by whole body imaging, which can be costly, complex, and time-consuming.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "We think that given the extremely small number of patients who even had test results that could be monitored for cancer growth \u2014 three people! \u2014 making broad claims about this being a low-cost alternative for all cancers is over the top. This is what the release says:\n\u201cFor monitoring patient tumors, only a handful of blood tests are available which are limited to only several types of cancers. Nearly all cancer patients require monitoring by whole body imaging, which can be costly, complex, and time-consuming. In contrast, molecular tests like the one we have developed will enable patients to be monitored at every visit, and thus have the potential for quickly tracking cancer growth and spread.\u201d\nDoes that sound like a test that was only used on six patients, only three of whom had detectable cancer?", "answer": 0}, {"article": "As most C. trachomatis infections are asymptomatic, chlamydia can often go untreated and lead to upper genital tract infections, pelvic inflammatory disease, and infertility.\nThe results look very promising, said senior author James Mahony, a professor of Pathology and Molecular Medicine for McMaster's Michael G. DeGroote School of Medicine and a researcher at St. Joseph Healthcare Hamilton's Research Institute where the work was performed.\nThis is why the promise of a vaccine would be extremely beneficial, says David Bulir, co-author of the study.\n\"The vaccine would be administered through the nose.\n\"Vaccine development efforts in the past three decades have been unproductive and there is no vaccine approved for use in humans,\" said Bulir, who just finished his PhD in medical sciences at McMaster.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "We would say that the entire release is unjustifiable given the lack of a mention of the true nature of the study. We also wonder if the investigators were given the opportunity to review the release before it went out.", "answer": 0}, {"article": "For more on multiple sclerosis, visit the National Multiple Sclerosis Society.\n\"And with the one oral option we have today, there has been a lot of concern over a possible risk for immune suppression and also an increased risk for cancer,\" added Zamvil, who was not a part of the current study team.\n\"We went 17 years with injectables before we got our first oral option, 'Gilenya', just last year.\n\"Each of the medications we have has a different mechanism of action,\" explained Dr. Gary Birnbaum, director of the MS Treatment and Research Center at the Minneapolis Clinic of Neurology.\nIn the two-year, double-blind Phase III trial, participants were randomly divided into two groups: those who were given a daily dose of laquinimod (0.6 milligrams) and those who were given a sugar-pill (placebo); neither the researchers nor the participants knew who received the medication or the placebo.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story does not rely solely on the news release from the American Academy of Neurology solely, but we were troubled by\u00a0how closely some of the sentences in the\u00a0story mirror\u00a0sentences in the news release. In particular, the story may lead readers to believe that the reporter sought out and interviewed the study\u2019s lead author, Dr. Giancarlo Comi, director of the department of neurology and the Institute of Experimental Neurology at the Scientific Institute and University Vita-Salute San Raffaele in Milan, Italy. His paraphrased comments are actually from a quotation in the press release.\nThe press release says: \u201c\u2019The incidence of liver enzyme elevation was higher in laquinimod treated patients,\u2019 said Comi. \u2018However, these elevations were temporary, reversible and did not lead to any signs of liver problems.'\u201d\nHere is the story\u2019s paraphrase: \u201cThe incidence of liver enzyme elevation was higher in patients treated with laquinimod, according to Comi, but he added that the elevations were temporary, reversible and did not lead to any signs of liver problems.\nBut because the story included input from independent experts, we\u2019ll give it the benefit of the doubt on this criterion.", "answer": 1}, {"article": "\"If someone said to my husband, 'I know this has been a rough road for you, and a big impact on your sex life, but if she stays on it another five years.\nYet Shockney says her husband of nearly 35 years would have wanted her to do everything possible to survive.\nThese drugs are slightly more effective than tamoxifen, although they don't work before menopause, Litton says.\nDoctors saw no increase in strokes, which has long been a concern with tamoxifen, Gray says.\nShockney asks.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "It\u2019s clear that the story did not rely on a news release.", "answer": 1}, {"article": "It is a bold move, but bold moves are what our patients deserve.\"\n\u201cI believe for the first time that we have treatments that are effective enough to make it possible to eradicate multiple myeloma definitively in a substantial proportion of patients, along with having the technology to detect that the disease has been targeted and that treatment can be stopped,\u201d said Luciano Costa, M.D., Ph.D., scientist at the UAB Comprehensive Cancer Center, lead of the Hematologic-Malignancy Working Group, and principal investigator of the MASTER study.\nMore than improving the results of the initial treatment, the MASTER study will treat patients for the necessary time to confirm elimination of minimal residual disease and then discontinue therapy.\nThis is one of the first trials in multiple myeloma to use minimal residual disease as primary endpoint and the very first one to modify therapy based on achievement of minimal residual disease eradication.\nThe hope is that the therapies will eradicate the disease in a significant proportion of patients and measure disease response more accurately than ever before.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "A quote from the lead investigator captures how this release dangles promises that go well beyond the evidence:\n\u201cI believe for the first time that we have treatments that are effective enough to make it possible to eradicate multiple myeloma definitively in a substantial proportion of patients, along with having the technology to detect that the disease has been targeted and that treatment can be stopped,\u201d said Luciano Costa, M.D., Ph.D.\nIn the interview noted above, Costa was careful to note that there is no proof this approach is better than existing treatments. The release should have highlighted similar basic caveats.", "answer": 0}, {"article": "\"These cells proliferated rapidly, and were susceptible to damage to their DNA - both factors that help them transition towards cancer,\" she said.\nProfessor Lindeman, who is also a medical oncologist at The Royal Melbourne Hospital, said the discovery of RANK as a marker of cancer precursors was an important breakthrough, because inhibitors of the RANK signalling pathway were already in clinical use.\nCurrent cancer prevention strategies for these women include surgical removal of the breasts and/or ovaries, which can have serious impacts on people's lives.\nIf confirmed in clinical studies, this would provide a non-surgical option to prevent breast cancer in women with elevated genetic risk.\n\"This is potentially a very important discovery for women who carry a faulty BRCA1 gene, who have few other options.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "The headline reads: \u201c\u2018Holy grail\u2019 of breast cancer prevention in high-risk women may be in sight.\u201d Phrases such as \u201choly grail\u201d are overused and, often, misleading. This was no exception. This is not only not a \u201choly grail,\u201d we don\u2019t know what it is yet. There are, to date, precisely zero results on human trials using denosumab to prevent breast cancer in women with the BRCA1 mutation. What\u2019s more, the category of women who are at high risk of breast cancer extends beyond those women with the BRCA1 mutation. For example, according to the National Cancer Institute, women with the BRCA2 mutation have a 45 percent chance of getting breast cancer by the age of 70. And the research discussed in this release doesn\u2019t have an apparent tie to BRCA2. In other words, the headline overreaches in two ways. Given that the headline is the first part of a release anyone sees, and sets the tone for the rest of the release, it\u2019s important to get it right.", "answer": 0}, {"article": "When a person has diabetes, their body either doesn't produce enough insulin or doesn't process blood sugar properly.\n\"You probably have to eat a lot of cocoa, and you probably don't want it to have a lot of sugar in it,\" said study author Jeffery Tessem, assistant professor of nutrition, dietetics and food science at BYU.\n\"These results will help us get closer to using these compounds more effectively in foods or supplements to maintain normal blood glucose control and potentially even delay or prevent the onset of type-2 diabetes,\" said study co-author Andrew Neilson, assistant professor of food science at Virginia Tech.\nBut rather than stocking up on the sugar-rich chocolate bars at the checkout line, researchers believe the starting point is to look for ways to take the compound out of cocoa, make more of it and then use it as a potential treatment for current diabetes patients.\nBut here's the thing: BYU researchers have discovered certain compounds found in cocoa can actually help your body release more insulin and respond to increased blood glucose better.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "The first quote in the release overwhelms all the cautionary statements that follow:\n\u201cYou probably have to eat a lot of cocoa, and you probably don\u2019t want it to have a lot of sugar in it,\u201d said study author Jeffery Tessem, assistant professor of nutrition, dietetics and food science at BYU. \u201cIt\u2019s the compound in cocoa you\u2019re after.\u201d", "answer": 0}, {"article": "October 26, 2017 - For younger patients with severe damage to the rotator cuff muscles, a \"reverse\" shoulder replacement provides lasting improvement in shoulder function, according to a study in The Journal of Bone & Joint Surgery.\nThe journal is published in partnership with Wolters Kluwer.\nThe new study focused on long-term outcomes of RTSA in patients under age 60.\nThe company, headquartered in Alphen aan den Rijn, the Netherlands, serves customers in over 180 countries, maintains operations in over 40 countries and employs 19,000 people worldwide.\nJBJS is an independent, non-profit journal.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "The release doesn\u2019t make use of unjustifiable language.", "answer": 1}, {"article": "Doctors who have turned surgery into a popular treatment for obesity are setting their sights on a burgeoning new market: diabetes patients.\n\nA growing amount of research suggests that bariatric surgery, which shrinks the stomach and sometimes reroutes the intestines, has a lasting effect on the most common form of diabetes, and not just because patients lose weight. Studies have found that more than 75% of patients with this type of diabetes who undergo the surgery see their disease disappear. They can go on to live diabetes-free...", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "There is no evidence the reporter has drawn information from a press release. ", "answer": 1}, {"article": "had lower HDL-cholesterol, lower income, and less education,\u201d in comparison to participants who did not consume red chili peppers.\nThe research is observational, so no cause and effect relationship can be established.\nParticipants were followed for an average of 18.9 years.\nLike spicy foods?\nIf so, science has some good news for you: Eating hot chili peppers may help you live longer.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story does not appear to rely on a news release.", "answer": 1}, {"article": "It takes an hour or less,\" he said.\nTwo patients died.\nVice President Dick Cheney is among the thousands of Americans who have one.\nOnly 18 percent decided to undergo replacement surgery.\nAnd not every failure is deadly.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "", "answer": 1}, {"article": "Smokers who count on nicotine patches or gum to help them quit may want to reconsider: A new study finds that these and other nicotine replacement products aren't effective at preventing former smokers from relapsing in real-world conditions.\nBut the latest results are in line with other studies that have found little \u2014 if any \u2014 benefit from the products when used by smokers in real life.\nThe findings run counter to the results of several randomized clinical trials conducted before the Food and Drug Administration gave the thumbs-up to these nicotine replacement products in the 1990s.\nIn those trials, volunteers using such products were up to three times more likely to kick the smoking habit.\nThose who had used nicotine patches, gum, inhalers or nasal sprays were just as likely to relapse as those who had quit without them, researchers from Harvard University and the University of Massachusetts found.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story did not rely on this press release from Harvard, but it did rely on this press release from GlaxoSmithKline, one of the big makers of nicotine replacement products. The dependence on the company\u2019s release for the sole outside perspective on the study casts a cloud over a story that already leaves too many questions unanswered. Fully 25% of the words in the story were turned over to the Glaxo response.\n\u00a0\n\u00a0", "answer": 0}, {"article": "Studies of large databases such as Medicare records or registries that enroll pregnant women already taking particular drugs are the chief ways to discover and measure possible risks to the fetus from prescription drugs.\nIt paid for the ACE-inhibitor study with help from the Agency for Healthcare Research and Quality.\nIt's considered unethical to include pregnant women in studies of new drugs unless the medication is intended to treat pregnancy-related conditions.\nThat such an effect was first noticed a quarter-century after ACE inhibitors arrived on the market points up the lack of data about the effect of drugs in pregnancy.\nIncreasingly, the FDA is seeking such data.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "There is no evidence that this story relied on a news release.", "answer": 1}, {"article": "Transcendental meditation involves shutting out the outside world and focusing thoughts inward, or resting while remaining alert.\nMORE: Losing Focus?\nMost doctors say meditation can\u2019t hurt you, but now there\u2019s reassuring evidence that it may help you as well when it comes to warding off disease.\nMost doctors say meditation can't hurt you, but now there's reassuring evidence that it may help you as well when it comes to warding off disease.\nThe great lengths to which the researchers of the Circulation study went to make their trial scientifically rigorous, however, should reinforce the results in the eyes of some skeptics.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story didn\u2019t rely inappropriately on this\u00a0press release.", "answer": 1}, {"article": "EMBARGOED UNTIL AUG. 14, 2017, AT 10 A.M. EDT\nIn the study, investigators injected cardiosphere-derived cells, a specific type of stem cell, from newborn laboratory rats into the hearts of rats with an average age of 22 months, which is considered aged.\nResults of those tests show lab rats that received the cardiosphere-derived cells:\n\u2022 Demonstrated longer heart cell telomeres, compound structures located at the ends of chromosomes that shrink with age\n\u2022 Improved their exercise capacity by an average of approximately 20 percent\n\u2022 Regrew hair faster than rats that didn't receive the cells\n\n\"This study didn't measure whether receiving the cardiosphere-derived cells extended lifespans, so we have a lot more work to do,\" said Lilian Grigorian-Shamagian, MD, PhD, co-primary investigator and the first author of the study.\n\"We have much to study, including whether CDCs need to come from a young donor to have the same rejuvenating effects and whether the extracellular vesicles are able to reproduce all the rejuvenating effects we detect with CDCs.\"\n\"Our previous lab studies and human clinical trials have shown promise in treating heart failure using cardiac stem cell infusions,\" said Eduardo Marb\u00e1n, MD, PhD, director of the Cedars-Sinai Heart Institute and the primary investigator of the study.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "The news release repeatedly uses speculative language:\nOf course while stem cells could do all of these things, they also could not do them.\nAlso egregious is a premature statement from lead researcher Eduardo Marban, who is married to the CEO of the company that makes the cells:\n\u201cThe way the cells work to reverse aging is fascinating,\u201d Marban said. \u201cThey secrete tiny vesicles that are chock-full of signaling molecules such as RNA and proteins. The vesicles from young cells appear to contain all the needed instructions to turn back the clock.\u201d", "answer": 0}, {"article": "\"So, yes, one of the limitations of this kind of study is always the question of its generalizability to other populations,\" he cautioned.\nSo, it's a very complex picture.\nWEDNESDAY, Feb. 6, 2013 (HealthDay News) -- Enduring dietary wisdom -- that polyunsaturated vegetable fats are better for your heart than saturated animal fats -- may be turned on its head by a fresh analysis of a nearly 50-year-old study.\n\"Because there's very robust evidence showing the cardiovascular benefit of linoleic acid.\n\"Those who are concerned should wait for more research to come out on this topic before taking any drastic measures to change their eating habits in a way that could be harmful.\"\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "There is enough original reporting that we can be sure the story didn\u2019t rely on a press release.", "answer": 1}, {"article": "Labovitz also points out that the group of men who had fewer strokes were younger, had lower blood pressure and smoked less than the group more prone to stroke.\nThough the study looks promising, experts say that we can't necessarily give all of the credit to lycopene.\nSo are lycopene packed tomatoes really the magic fruit?\nIt seems the jury is still out, but researchers suggest we eat healthy as they continue to search for answers.\n\"But it's not proof that if you eat tomatoes you're going to have less risk of stroke.\"\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "There is enough independent perspective in this piece that we can be sure it wasn\u2019t based on a press release.", "answer": 1}, {"article": "Although the use of NSAIDs for arthritic conditions such as knee OA has potential risks, including heart attack and stroke, existing evidence indicates that naproxen has less potential for adverse cardiovascular events.\nAuthors analyzed 53 randomized controlled trials that examined knee OA treatments for at least 28 days and included a minimum of 30 participants per study group.\n\"Because knee OA has both a high disease burden and high treatment costs, additional prospective studies using similar outcomes, timelines, and measures of clinically important changes are needed,\" explained Dr. Jevsevar.\nThis new research analyzed data from multiple trials to determine the relative effectiveness of various nonsurgical treatments for knee OA.\n\"While the information in this analysis is helpful to physicians, patients also can benefit from these findings and use it with their doctors to weigh all possible treatment options.\"\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "This news release clearly summarizes the main conclusions of the researchers\u2019 journal article. Other than repeating the questionable estimate of lifetime risk of knee osteoarthritis noted above, the language of the release is moderate and useful.", "answer": 1}, {"article": "Levels of the biomarker were lower in mild cases, and were much more elevated in severe case,\" said Papa.\nResearchers plan to do more studies with the blood test, but they hope it will be commercially available within the next 5 years.\nEven more impressive, the blood test also gave doctors an indication of how severe the brain injury was.\nMoreover, the study showed that the blood test detected symptoms of concussions, even when brain injuries were not visible on the CT scan.\nNeither scenario gives doctors an objective indication of the severity of the injury.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "The release calls the test \u201csimple\u201d in several places whereas our review shows that it would be anything but. Some other examples of hyperbole: \u201cConcussions in kids are detectable by blood test,\u201d \u201cBlood test is 94 percent reliable in detecting concussions in kids, confirmed by CT scans.\u201d \u00a0The story backs off in the last line that states \u201cResearchers plan to do more studies with the blood test, but they hope it will be commercially available within the next 5 years.\u201d \u00a0That\u2019s not quite good enough, however. \u00a0In the published results, the authors stated more appropriately, \u201cFurther study is required to validate these findings before clinical application.\u201d", "answer": 0}, {"article": "Alcohol consumption may also protect people who already have the autoimmune disease from developing a more debilitating form.\nGuy Fiocco, assistant professor of internal medicine at Texas A&M Health Science Center College of Medicine and director of rheumatology at Scott & White in Temple, Texas.\n\"This actually isn't a new concept.\nNor do the study authors advise drinking as a cure for arthritis.\nThis finding is slightly different than what is reported in the current study (that the severity of the disease decreased with more alcohol).\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "Does not appear to have relied on a news release.", "answer": 1}, {"article": "All of the babies born by C-section were slightly more likely to use an asthma inhaler at age 5: 10.3 percent of planned C-section babies and 10.19 percent of unscheduled C-section babies wound up using an inhaler, compared with 9.6 percent of vaginally born babies.\nEven attempted labor may provide some exposure to bacteria, she said.\nThe findings are a reminder that although C-sections are appropriate in some circumstances, they are a poor substitute for labor.\nThe Scottish study took advantage of the small country\u2019s rich trove of linked birth and medical databases to track the long-term health of 321,287 babies.\nThe new findings, published in JAMA this month, are important because the number of babies born by C-section has increased tremendously.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story did not rely on a news release.\u00a0There is evidence of independent reporting.", "answer": 1}, {"article": "A widely anticipated study suggests that hormone therapy started soon after menopause can ease depression, anxiety, hot flashes and other adverse symptoms that many women face, without increasing risks for cardiovascular disease.\n\nThere was no increase in breast cancer, stroke, heart attack or blood clots, but the study's researchers said the sample size was too small and the study time too short to draw firm conclusions.", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story does not appear to rely on a press release, as there is evidence of original reporting with the two quotations.", "answer": 1}, {"article": "LONDON (Reuters) - First results from a human trial of an Ebola vaccine from GlaxoSmithKline show it is safe and generates an immune response, scientists said on Wednesday, but larger trials are needed to see if it protects and if a booster is needed.\nJeremy Farrar, director of the Wellcome Trust charity which helped fund the trial, said it provided \u201cgood initial evidence that the GSK vaccine will be safe to use in people\u201d.\n\u201cThe safety profile is pretty much as we\u2019d hoped and the immune responses are okay, but not great,\u201d he told Reuters.\n\u201cPeople typically experienced mild symptoms that lasted for one or maybe two days, such as pain or reddening at the injection site, and occasionally people felt feverish,\u201d Hill said.\n\u201cThat\u2019s why trials in West Africa of this, and the other vaccines in development, must begin as soon possible.\u201d\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story included two interviews and clearly went beyond any news release that may have been issued.", "answer": 1}, {"article": "In the current review, researchers found several trials that compared different doses of radiation and different types of radiation therapy, including external beam radiation therapy, in which a radiation is delivered through a beam through the skin, or brachytherapy, in which radioactive isotopes are delivered via injection into the prostate.\n\"Some of the distinctions being made are not really supported by the evidence.\"\nIn part, that's because researchers found no randomized controlled trials -- considered the gold standard of research -- that compared radiation therapy with watching waiting, Ip said.\nFor those methods, too, there was too little research to say with confidence which method was superior in preventing deaths from prostate cancer, the researchers said.\nFinally, patients and their doctors should weight the potential debilitating side effects of the treatments, such as incontinence and erectile dysfunction, against how comfortable the man is with holding off on treatment, experts say.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story did not rely solely on a news release.", "answer": 1}, {"article": "\"These are children who could have died from a teaspoon of milk before,\" Wood said.\nShe drinks chocolate milk.\nShe eats yogurt.\nShe eats cheese.\nReagan is one of a small number of children who have undergone an experimental treatment that is showing promise for treating milk, peanut and other food allergies.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "Does not appear to rely on a press release.\u00a0 ", "answer": 1}, {"article": "Previous studies have shown that nitrites \u2014 also found in high concentrations in celery, cabbage, and other leafy, green vegetables like spinach \u2014 widen blood vessels, but researchers say this was the first to find that nitrites also increase blood flow to the brain .\nAn hour later, an MRI scan recorded brain flow in each person\u2019s brain.\nThe high-nitrate breakfast included 16 ounces of beet juice.\nThen they were sent home with lunch, dinner, and snacks that conformed to their assigned diets.\nOn the second day, after another 10-hour fast, the participants returned to the lab and ate their assigned breakfasts.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The story was nothing more than a rewrite and a rearrangement of a Wake Forest University news release.", "answer": 0}, {"article": "Dr. Jean-Yves Reginster of Liege State University in Belgium and colleagues recruited 604 people over age 50 with knee osteoarthritis from five European countries and randomly assigned them to take 800 mg of the extra-pure chondroitin sulfate (Chondrosulf), 200 mg of celecoxib (Celebrex) or a placebo every day for six months.\n\u201cHowever, it should not replace other therapy such as quad strengthening exercises, and weight loss, which we know will provide benefit.\nIn addition, U.S.-based studies of chondroitin have had mixed results, said Shepard, who wasn\u2019t involved in the study.\nDr. Michael Shepard of Hoag Orthopedic Institute in Orange, California, noted that the study had a relatively low number of participants and that most U.S. studies of this type would run two years rather than six months.\n\u201cStudies like this highlight that medicine is still an art - we do not have perfect answers, and we have to individualize for each patient.\u201d\n\nThe study was sponsored by IBSA Institut Biochimique SA, a pharmaceutical company based in Lugano, Switzerland, that makes the chondroitin sulfate supplements used in the test.\n", "question": "Does the story appear to rely solely or largely on a news release?", "explanation": "The article does not appear to rely on a news release.", "answer": 1}, {"article": "Pancreatic cancer is the fourth leading cause of cancer-related death in both men and women in the United States.\n\"While more study is needed, the general population should strive to get the daily recommendations of magnesium through diet, such as dark, leafy greens or nuts, to prevent any risk of pancreatic cancer.\"\n\"The five-year survival rate is really low, so that makes prevention and identifying risk factors or predictors associated with pancreatic cancer very important.\"\nBut few studies have explored the direct association of magnesium with pancreatic cancer; of those that did, their findings were inconclusive, said Daniel Dibaba, a Ph.D. student at the School of Public Health-Bloomington, who led the IU study.\nThe study found that every 100-milligrams-per-day decrease in magnesium intake was associated with a 24 percent increase in the occurrence of pancreatic cancer.\n", "question": "Does the news release include unjustifiable, sensational language, including in the quotes of researchers?", "explanation": "The release doesn\u2019t come right out and say that taking magnesium will reduce pancreatic cancer risk but it comes close. Instead, it hedges on making that claim with phrases like \u201cmay be beneficial\u201d and \u201cmay prove beneficial.\u201d Based on limited available knowledge, it\u2019s appropriate to share the information that getting the recommended daily allowance of magnesium may have specific health benefits.", "answer": 1}]